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Abstract
The simultaneous control of diastereoselectivity and regioselectivity in Zncatalyzed allenylation reactions of N-protected L-α-amino aldehydes is reported. A
reversal in diastereoselectivity could be realized by variation of the ɑ-amino aldehyde
protecting groups. A range of 1-allenyl-2-amino alcohols were obtained with
excellent regioselectivity and converted to oxazolidinones and dihydrofurans. Many
of which could be isolated as single diastereoisomers and without significant erosion
of ee, making this a practical catalytic synthesis of highly functionalized heterocycles.

Introduction
Allenyl and propargyl boronates have emerged as key reagents for catalyzed
allenylation and propargylation reactions of carbonyls and imines, providing rapid
synthesis of allenes and alkynes with pendant heteroatoms via C–C bond formation.1
Allenes are valuable intermediates for target-oriented synthesis and methodology
development because they can undergo a vast array of transformations and have high
levels of structural diversity.1e Allenes bearing pendant heteroatoms, such as N or O,
are particularly important due to the ability of these heteroatoms to engage in
cyclization reactions with the reactive allene moiety – typically under the catalysis of
π-philic transition metals.2 Furthermore, a number of natural products and
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pharmaceuticals feature allenes with pendant heteroatoms.3
A powerful route to allenes with a pendant O has been developed by Fandrick
et al. who have demonstrated that Et2Zn catalyzes the regioselective allenylation of
various achiral aldehydes and ketones with allenylboronic acid pinacol ester 1
(Scheme 1a).4a This seminal study indicated that this was a kinetically controlled
process, where addition of a catalytically generated propargyl zinc intermediate to the
carbonyl electrophile competes with equilibration of the propargyl and allenyl
intermediates. They also demonstrated that a regiochemical switch to the more typical
homopropargyl alcohols was possible when the reaction was run at room temperature
and under thermodynamic control.4b More recently, Kobayashi showed that a
Zn(HMDS)2-catalyst process with allenylboronic acid 2,2-dimethyl-1,3-propanediol
ester 1ʹ could also give either the allenyl or homopropargyl alcohols from the same
starting materials by using kinetic or thermodynamic reaction control, respectively
(Scheme 1a).5 Despite these reports, methods to prepare allenes with multiple pendant
heteroatoms are extremely rare6 and mostly limited to systems containing only
oxygen, rather than both O and N; furthermore, the methods that do exist are not
catalytic.7 Combining both O and N reactive elements in a single allenic substrate
would allow the synthesis of highly functionalized heterocycles with multiple
heteroatoms. However, the potential route to these compounds via catalytic
allenylation of α-amino aldehydes8 (A, Scheme 1b) has not been developed; although
the preparation of propargyl amino alcohols by the stoichiometric addition of
propargylzinc species to α-amino aldehydes has been established.9 Such a method
would be challenging due to the requirement for concurrent control of both
regioselectivity and diastereoselectivity – something that has not been achieved to
date. Herein, we report a simultaneous control of diastereoselectivity and

2

regioselectivity in the Et2Zn-catalyzed allenylation reactions of chiral α-amino
aldehydes with allenylboronic acid pinacol ester 1.

Scheme 1. (a) Previous methods for the preparing allenylcarbinols from
allenylboronic reagents 1 and 1ʹ using zinc catalysts; (b) current study.

The resulting allenic products are direct precursors to 2,5-dihydrofurans with a
pendant N (25, Scheme 1b) and allenyloxazolidinones (23, Scheme 1b), which are
two key heterocycles in a diverse array of biologically active structures, fragrance
compounds, antirheumatics and antidiabetics.10,11 Diastereoselective methods to
prepare oxazolidinones with pendant unsaturated moieties are severely limited,12 and
while the preparation of 2,5-dihydrofurans by Au-catalyzed cyclisation of allenes is
3

well known, the same method to 2,5-dihydrofurans with pendant N are unknown – the
only other routes involve long non-general multi-step synthesis.13

Results and Discussion
The L-alanine-derived N-Boc protected α-amino aldehyde 2a8 was first chosen
for investigation of these reactions using diethylzinc as a catalyst under the reaction
conditions shown in Table 1. We chose to focus on diethylzinc as it is a commercially
available and mild reagent unlikely to cause racemization of the α-amino aldehyde
starting materials. When the reaction of allenyl boronate 1 and the aldehyde 2a was
conducted in toluene in the absence of Et2Zn (entry 1), a slow background reaction
was observed to give only propargyl amino alcohol 16a, in low yield and with low
diastereoselectivity. The addition of 5 mol% of the Et2Zn catalyst resulted in a more
rapid reaction to give the allene 9a with almost complete control of allenyl to
propargyl regioselectivity, but with modest syn diastereoselectivity (entry 2).
Switching to the more polar solvent THF resulted in the reversal of regioselectivity to
favour the propargyl product 16a, but with almost no diastereoselectivity (entry 3).
The reaction also proceeded in CH2Cl2 but with modest regioselectivity (entry 4). An
increase in the amount of catalyst from 5 mol% to 10 mol% in toluene improved the
yield significantly from 77% (entry 2) to 92% (entry 5), with moderate
diastereoselectivity. In an attempt to improve the diastereoselectivity, the reaction was
conducted at −40 °C (entry 6), but no reaction was observed.
At this point alternate protecting groups on the nitrogen were investigated in
an attempt to further control the diastereoselectivity. The N-Ts and N-Fmoc alanals 3
and 4 (entries 7 and 8) did not undergo the desired allenylation/propargylation
reaction, while N-Tr alanal 5 (entry 9) provided the corresponding 1-allenyl-2-amino
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alcohol in high yield and regioselectivity – however, the diastereoselectivity was
poor. After testing a range of singly N-protected α-amino alanals, N,N-diprotected αamino alanals were investigated to see if a switch in diastereoselectivity was possible
by virtue of increased steric bulk at the nitrogen of these substrates (entries 10-12).14
The reaction of the N-Bn, N-Boc alanal 6a proved the most rewarding giving the
allenyl product 13 with good regioselectivity (89:11) and high diastereoselectivity (dr
=19:1 anti:syn).
Table 1. Optimization of reaction conditionsa

Entry

NR1R2

Sol.

1
2
3
4
5
6
7
8
9
10
11
12

NHBoc
NHBoc
NHBoc
NHBoc
NHBoc
NHBocd
NHTs
NHFmoc
NHTr
NBnBocg
NBnTsg
NBn2g

PhMe
PhMe
THF
CH2Cl2
PhMe
PhMe
PhMe
PhMe
PhMe
PhMe
PhMe
PhMe

Cat.
(mol %)
0
5
5
5
10
10
10
10
10
10
10
10

Yieldb %
(al:pr)c
12 (0:100)
77 (97:3)
60 (5:95)
38 (71:29)
92 (93:7)
0
0e
0f
82 (84:16)
96 (89:11)
54i (94:6)
50i (94:6)

drc
(syn:anti)
2.6:1
2.6:1
1.1:1
2:1
2.6:1
0
0
0
1.3:1
1:19h
1:1.5
1:1.3

a

Reaction conditions: 1 (1.10 equiv.), Et2Zn, solvent, 0 oC, 18 h.
Isolated yield of allene and propargyl products.
c
Regioselectivity of determined by 1H NMR analysis of the
crude reaction product – stereochemistry of propargyl products
not determined. dThe reaction was carried out at -40 oC.
e
Decomposition of SM. fRecovery of SM. g1.3 equiv. of 1 was
used. hDetermined by 1H NMR analysis of N-Boc deprotected
crude RM. Lowering of the catalyst loading for this substrate
resulted in incomplete conversion. iIsolated yield for the major
allene diastereoisomer.
b

The anti and syn configurations assigned to 9a and 13a, respectively, were
based on 1H NMR analysis, including the nOe interactions between H4, H5 and the
CH3 group in the corresponding oxazolidinones 23a and 24 (Scheme 2) and the
5

magnitudes of J4,5 couplings (J4,5 = 6.0 Hz for 23a and J4,5 = 7.2 Hz for 24) which
were also consistent with these assignments.6a It is proposed that the syn
diastereoisomer is likely formed via a Cram−chelate-like model, where interaction
between the aldehyde and the N-H drives the direction of nucleophilic attack.
(Scheme 2a).14e,f Conversely, switching to the aldehyde having a more steric bulky,
doubly protected, nitrogen favors Felkin−Ahn control as H-bonding is no longer
possible (Scheme 2b).14a-d That the dr for the uncatalyzed reaction (Table 1, entry 1) is
identical to the catalyzed provides further support for this H-bond model, rather than
Zn playing a role in chelation.
Scheme 2. Determination of relative configuration of the allenyl products.

While only a moderate diastereoselectivity was observed for the allenylation of N-Boc
protected α-amino aldehyde 2a, the reactions are highly regioselective. Furthermore,
the levels of diastereoselectivity observed in Table 2 are comparable to the recently
reported cross-benzoin condensation using N-Boc protected α-amino aldehydes.14d,e
We found that base-induced conversion to the allenyl oxazolidinones 23 provides a
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convenient method for producing regio- and diastereomerically enriched products (up
to >98:2 for the majority of cases) after chromatographic purification for the removal
of the minor diastereomer.
Table 2. Reaction
oxazolidinonesa

1-allenyl-2-aminoalcoholsb,c

scope

of

5-allenyl

5-allenyl oxazolidinoneb,c

a

Reaction conditions: (i) 1 (1.1 equiv.), Et2Zn (10 mol%),
toluene, 0 oC, 18 h; (ii) NaH (2 equiv.), THF, r.t, 1.5 h.
b
Isolated yield, with dr measured on purified oxazolidinone
after chromatographic purification. cRegioselectivity and dr
estimated by 1H NMR analysis of purified 9. dIsolated yield of
the single major diastereomer. eee was determined by 1H NMR
analysis
of
the
resulting
diastereomeric
(S)-
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camphorsulfonamide derivatives (see SI).

These structures are more convenient building blocks than the precursor Nprotected amino-alcohols as their NMR spectra are more clearly defined due to the
absence of rotamers and they have a rigid stereodefined oxazolidinone unit combined
with a reactive allene moiety. This is the first example of oxazolidinones bearing a
reactive C5 allenyl side chain along with the free NH,15 which suggests they should be
powerful synthetic intermediates for the synthesis of biological active compounds.
Therefore, the optimized reaction conditions for the Zn-catalyzed allenylation
reactions were performed for other chiral N-Boc α-amino aldehydes having different
aryl and aliphatic side chains, before conversion to the corresponding allenyl
oxazolidinone (Table 2). These reactions afforded the syn 1-allenyl-2-amino alcohols
9a-9f with high regioselectivities and generally provided high yields (70-92%) and
moderate to high diastereoselectivities (2.3:1−9:1 syn/anti). For the aliphatic R
substituents, the dr improved as the size of the R group of 2 increased from Me (2a)
to i-Pr (2d). The 1-allenyl-2-amino alcohol products underwent base-induced
cyclisations to give 5-allenyloxazolidinones 23a-23f which could be isolated in yields
of 50-74% – in the majority of cases (23a-c and 23f) these were obtained as single
diastereomers,

after

separation

of

the

major

diasteromer

using

column

chromatography, thus providing practical access to these intriguing heterocycles.12,15
We next explored the substrate scope of the allenylation reaction of the N-Bn,
N-Boc aldehydes 6. The NMR spectra for the direct allenylation products are
complicated by the presence of a mixture of rotamers, diastereoisomers and
regioisomers, therefore dihydrofurans 25 were targeted as the final desired products.16
Consequently, following allenylation of aldehydes 6a-g under the optimized
conditions, a sequential Au(I)-catalyzed cyclization17 and N-Boc deprotection was
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carried out on the crude reaction mixture to give dihydrofurans 25 in good three-step
yields (Table 3). In three cases, the products (25a, 25d and 25f) could be obtained as
single diastereoisomers after purification by column chromatography and the others in
good to modest dr. The dr as estimated by the 1H NMR of the crude dihydrofurans
(25) is essentially the same as the purified material, expect for 25f, which showed a dr
of 4.9:1 in the crude reaction mixture, indicating the minor diastereomer had been
removed during purification. This method is advantageous for two reasons, firstly the
dihydrofurans are medicinally important skeletons and secondly, the direct N-Boc
deprotection of allene products 13 resulted in formation of an unstable product.18
Despite the importance of these structures, we are unaware of any general methods to
prepare 2,5-dihydrofurans with a pendant nitrogen atom – let alone in a stereodefined
fashion. The N-Boc protected proline-derived amino aldehyde 6g performed well in
the reaction to give 13g, and then the corresponding cyclized material 25g. The
corresponding deprotected derivative proved unstable, which is consistent with
previous reports.19

9

Table
3.
Reaction
a,b,c
dihydrofurans

scope

of

2,5-

a

Reaction conditions: (i) 1 (1.3 equiv.), Et2Zn (10 mol%), PhMe, 0
C, 18 h; (ii) AuPPh3NTf2 (10 mol%), DCE, 60 oC, 8 h; (iii)
TMSCl (5 equiv.), MeOH, r.t, overnight. bIsolated yields over
three steps without any intermediate purification. cdr determined
by 1H NMR analysis of purified 25. dThe N-Boc deprotected
product could not be obtained due to instability. eIsolated yield
from two steps.

o

All the α-amino aldehydes utilized in this study were enantiomerically
enriched and obtained from naturally occurring L-α-amino acids and are generally
known for their propensity to racemization.8 Therefore, the enantioretention of
representative reactions from Tables 2 and Table 3 were investigated and gratifyingly,
no erosion of enantiopurity was observed in any case. The ees of diastereomerically
enriched oxazolidinones 23a-c and 23f were determined by preparation of their (S)camphorsulfonyl derivatives according to the previously reported method20 (see SI).
The ees of 23a (ee 96%) and 23c (ee 86%) were identical to those of their precursor
aldehydes 2a (ee 96%)8 and 2c (ee 86%), which indicates little or no erosion of the
10

enantiomeric purities of the aldehydes during the reaction steps (aldehyde ee from
chiral HPLC analysis of the corresponding alcohol, see SI). However, this method
was not suitable for the 2,5-dihydrofuran products 25 due to instability of the
corresponding camphorsulfonyl derivative. Therefore, the ee of the precursor
aldehyde 6a (ee 91%) was determined by chiral HPLC (see SI), which was identical
to that of its derived dihydrofuran 25a (ee 91%, from chiral HPLC analysis, see SI).
The proposed mechanism for these allenylation reactions is shown in Scheme
3 and is consistent with the proposal of Fandrick and co-workers.4 Transmetallation
between 1 and Et2Zn gives the reactive propargylic Zn species B, which under the
kinetic control conditions of the reaction reacts in an SE2ʹ fashion with the α-amino
aldehyde under Felkin−Ahn or Cram−chelation-like control to give Zn alkoxide C.
The reaction remains catalytic in Zn as the alkoxide can undergo B-to-Zn exchange
with 1 to regenerate the propargyl zinc species B.
Scheme 3. Proposed catalytic cycle for the Zn-catalyzed allenylation reactions

11

It is also possible that Et2Zn is regenerated by reaction of the alkoxide C with
EtBpin generated in the initial transmetallation. Isomerisation of propargylic Zn
species B to the thermodynamically more stable allene species D under our reaction
conditions is clearly facilitated by more polar solvents, such as THF (entry 3 of Table
1).
In conclusion, we have developed the first examples of simultaneous control
of diastereoselectivity and regioselectivity in Zn-catalyzed allenylation reactions of Nprotected L-α-amino aldehydes. These reactions proceed with high regiochemical
control to favor the allenic products. Felkin−Ahn control is observed in the presence
of sterically hindered groups on nitrogen, while Cram−chelation like control is
observed for singly protected α-amino aldehydes. Furthermore, the products of these
allenylation reactions undergo intramolecular cyclization to obtain novel 5-allenyl
oxazolidinones and 2,5-dihydrofurans. Many of these heterocyclic compounds could
be obtained as single diastereomers in high ee after simple column chromatography,
making this a practical method for preparing these highly functionalized and useful
chiral scaffolds. Work is currently underway to investigate the reactivity of the
allenyloxazoldinone products.

Experimental Section
General Methods. Commercial reagents were purchased and used as received
without any purification. Dry reaction solvents were passed through activated alumina
columns to obtain dryness before being stored under nitrogen over 4Å molecular
sieves. All reactions using air/moisture sensitive reagents were performed in ovendried glassware, under an atmosphere of nitrogen quipped with a stir bar. Reactions
were monitored by thin-layer chromatography (TLC) on aluminum backed silica gel
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sheets, visualizing with UV-light (254 nm) fluorescence quenching, followed by
staining of the plates with potassium permanganate stain. Column chromatography
used for compound purification was performed using pre-packed flash grade silica gel
(40-75 nm) as the stationary phase. 1H NMR and

13

C{1H} NMR spectra were

recorded either at 300, 400 and 500 MHz 1H NMR or at 75, 100 and 125 MHz
NMR. All 1H NMR and

13

C

13

C{1H} NMR were recorded in deuterated chloroform

(CDCl3) containing 0.1% (v/v) tetramethylsilane (TMS). Abbreviations used in the
description of resonances are: singlet (s), doublet (d), triplet (t), quartet (q), doublet of
doublets (dd), broad (br) and multiplet (m). All coupling constants (J) were measured
in hertz (Hz). NMR chemical shift abbreviations were reported in parts per millions
(ppm) from tetramethylsilane (TMS) and were corrected to 0.00 ppm (TMS) for 1H
NMR and 77.00 ppm (CDCl3 centre line) for

13

C NMR. The α-amino amino methyl

ester hydrochlorides were prepared from commercially available amino acids using
previously reported literature procedures (citations to these compounds are provided
in the experimental below).

Synthesis of singly N-protected-amino Aldehydes
The N-protected α-amino aldehydes 2a,21a 2c,21b 2d,21c 2e,21d 321e, 421f and 521g are
known and were prepared by the previously reported methods.

Methyl (S)-tert-butyl(1-oxopentan-2-yl)carbamate (2b).
Methyl 2-((tert-butoxycarbonyl)amino)pentanoate S1. To a solution of methyl
2-aminopentanoate hydrochloride22a (1.00 g, 5.96 mmol) in dry dichloromethane (15
mL) at 0 °C, was added triethylamine ((0.94 mL, 6.55 mmol, 1.1 equiv.), followed by
di-tert-butyl dicarbonate (1.56 g, 7.16 mmol, 1.2 equiv.). Stirring was continued for 1
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h at 0 °C, and then overnight at room temperature. The reaction mixture was then
quenched by the addition of saturated aqueous NaHCO3(aq) solution and the separated
organic layer washed with brine solution and dried over Na2SO4. Purification by flash
column

chromatography

(EtOAc/hexane

3:7)

yielded

methyl

2-((tert-

butoxycarbonyl)amino)pentanoate S1 as a colorless oil (1.29 g, 93% yield). 1H NMR
matched that reported previously, but other characterization data has not been
published so is included here.23 Rf (Et2O/hexane 2:8) = 0.42. 
 = +84.6 (c 2
CHCl3). 13C{1H} NMR (125 MHz, CDCl3) δ 13.5, 18.5, 28.1, 34.6, 52.0, 53.1, 79.5,
155.3, 173.4. IR (νmax/cm-1) 3370 (w), 2963 (m), 2934 (m), 1743 (s), 1713 (s), 1507
(s), 1365 (s), 1249 (s), 1159 (s), 1011 (m), 779 (m). HRMS (ESI-TOF) m/z calcd for
C11H21NO4Na [M + Na]+ 254.1368, found 254.1361.
Methyl (S)-tert-butyl(1-oxopentan-2-yl)carbamate (2b). To a solution of
methyl 2-((tert-butoxycarbonyl)amino)pentanoate S1 (0.19 g, 0.82 mmol) in dry
toluene (2 mL) at −78 °C, was added dropwise diisobutylaluminum hydride (5.5 M in
n-hexane, 0.30 mL, 1.64 mmol, 2 equiv.) over a period of 45 min. The mixture was
stirred at the same temperature for 1.5 h, and then quenched by the addition of
precooled methanol. The reaction mixture was allowed to warm to room temperature,
ice (1 g) was added with heavy agitation, the mixture filtered and the filtrate was
extracted with chloroform. The organic layer was washed with brine solution, dried
over Na2SO4 and concentrated under reduced pressure to 2b as a colorless oil which
was used without further purification (0.149 g, 91% yield). The data matched that
previously reported.24

(S)-tert-Butyl 3-(2-((tert-butoxycarbonyl)amino)-3-oxopropyl)-1H-indole1-carboxylate (2f).
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tert-Butyl

3-(2-((tert-butoxycarbonyl)amino)-3-methoxy-3-oxopropyl)-1H-

indole-1-carboxylate S2. Triethylamine (0.56 mL, 3.92 mmol, 1.0 equiv.) was added
dropwise to a stirred solution of methyl tryptophanate hydrochloride22b (1.00 g, 3.92
mmol) in THF (15 mL) at 0 oC. Then, di-tert-butyl dicarbonate (1.71 g, 7.85 mmol,
2.0 equiv.) and 4-(dimethylamino)pyridine (0.72 g, 5.88 mmol, 1.5 equiv.) were
added and the mixture was stirred overnight at room temperature. The reaction
mixture was concentrated under reduced pressure, and the tert-butyl 3-(2-((tertbutoxycarbonyl)amino)-3-methoxy-3-oxopropyl)-1H-indole-1-carboxylate

S2

was

obtained after flash column chromatography (EtOAc/hexane 3:7). Colorless oil (1.59
g, 97%). The data recorded matched that previously reported.25
(S)-tert-Butyl

3-(2-((tert-butoxycarbonyl)amino)-3-oxopropyl)-1H-indole-1-

carboxylate (2f). The title compound 2f was obtained following the same procedure
used

for

2b

with

tert-butyl

3-(2-((tert-butoxycarbonyl)amino)-3-methoxy-3-

oxopropyl)-1H-indole-1-carboxylate S2 (0.11 g, 0.26 mmol) and diisobutylaluminum
hydride (5.7 M in n-hexane, 0.10 mL, 0.57 mmol, 2.2 equiv.) in toluene (1 mL).
1
Colorless gummy oil (0.064 g, 99% yield). 
 = +53.5 (c 3.2 CHCl3). H NMR

(500 MHz, CDCl3) δ 1.44 (s, 9H, C(CH3)3), 1.66 (s, 9H, C(CH3)3), 3.22 (br s, 2H,
CH2Ph), 4.48 (br s, 1H, CH), 5.22 (br s, 1H, NH), 7.25 (br s, 1H, CHAr), 7.32 (br s,
1H, CHAr), 7.43 (br s, 1H, CHAr), 7.54 (br s, 1H, CHAr), 8.13 (br s, 1H, CHAr), 9.65 (s,
1H, CHO).

13

C{1H} NMR (125 MHz, CDCl3) δ 25.0, 28.2, 28.3, 59.6, 80.2, 83.8,

114.8, 115.3, 119.0, 122.7, 124.2, 124.7, 130.2, 135.5, 149.5, 155.4, 199.5. IR
(νmax/cm-1) 3371 (w), 2979 (m), 2361 (w), 1730 (s), 1700 (s), 1507 (s), 1452 (s), 1367
(s), 1253 (s), 1154 (s), 1086 (s), 856 (m), 766 (s), 744 (s). HRMS (ESI-TOF) m/z
calcd for C21H28N2O5Na [M + Na]+ 411.1896, found 411.1878.
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Preparation of doubly protected α-amino esters and aldehydes
The N-Bn,N-Boc α-amino aldehyde 6e26 and the N-Boc α-amino prolinal 6g27,
N-Bn,N-Ts α-amino alaninal 728 and N,N-dibenzyl-α-amino alaninal 829 are known
and were prepared by the previously reported methods. The remaining N-Bn,N-Boc αamino aldehydes were prepared as described below. The starting materials methyl
tosyl-L-alaninate21e, (S)-tert-butyl benzyl(1-hydroxypropan-2-yl)carbamate30a, (S)methyl N-benzyl valinate

31a

and (S)-2-(benzylamino)-3-methylbutan-1-ol31b were

prepared as previously described.

tert-Butyl benzyl(1-oxopropan-2-yl)carbamate 6a.
To a stirred solution of tert-butyl benzyl(1-hydroxypropan-2-yl)carbamate30a (0.42 g,
1.58 mmol) in CH2Cl2 (30 mL) at 0 °C, was added saturated aqueous NaHCO3
solution (15 mL), KBr (0.18 g, 1.58 mmol, 1.0 equiv.) and TEMPO (12.35 mg, 0.079
mmol, 0.05 equiv.). NaOCl (3.79 mL, 1.89 mmol, 1.2 equiv.) was then added with a
syringe pump over 30 min. The reaction was stirred for another 15 min at 0 °C. Then,
the reaction mixture was quenched with saturated aqueous Na2S2O3 solution (15 mL)
and extracted into CH2Cl2 (3×10 mL). The combined organic layers were dried
(Na2SO4) and concentrated under reduced pressure to afford the aldehyde 6a, which
was utilized for the next step without purification. Colorless oil (0.38 g, 91%). The ee
was determined by chiral HPLC analysis of the corresponding alcohol (obtained by
NaBH4 reduction of a small quantity of the unpurified aldehyde) using a Phenomenex
Lux i-Cellulose-5 column; hexane/isopropanol (95:5); flow rate = 0.5 mL/min; 210
nm; tmajor = 23.29 min, tminor = 25.15 min, 91% ee. The data matches that
previously reported.30b

16

(S)-tert-Butyl benzyl(1-oxopentan-2-yl)carbamate (6b).
Methyl 2-(benzylamino)pentanoate S3. To a stirred suspension of L-norvaline
methyl ester hydrochloride22a (1.30 g, 7.75 mmol) and benzyl bromide (0.90 mL, 7.75
mmol, 1.0 equiv.) in acetonitrile (20 mL), was added potassium carbonate (2.14 g,
15.50 mmol, 2.0 equiv.) and the mixture was stirred overnight at room temperature.
The reaction mixture was washed with saturated aqueous NH4Cl solution (30 mL) and
water (30 mL), dried (MgSO4), concentrated under reduced pressure and purified by
flash column chromatography (Et2O/hexane 1:9) to obtain the N-benzylated product
S3. Colorless oil (1.25 g, 73%). Rf (Et2O/hexane 1:9) = 0.16. 
 = −35.4 (c 5.5
CHCl3). 1H NMR (300 MHz, CDCl3) δ 0.88 (t, 3H, J = 7.2 Hz, CH3), 1.33-1.43 (m,
2H, CH2), 1.57-1.64 (m, 2H, CH2), 1.79 (s, 1H, NH), 3.26 (t, 1H, J = 6.6 Hz, CH),
3.61 (d, 1H, J = 13.2 Hz, CHPh), 3.67 (s, 3H, CH3), 3.80 (d, 1H, J = 12.9 Hz, CHPh),
7.22-7.31 (m, 5H, 5CHAr). 13C{1H} NMR (125 MHz, CDCl3) δ 13.8, 19.0, 35.7, 51.5,
52.1, 60.5, 126.9, 128.2, 128.3, 139.9, 176.0. IR (νmax/cm-1) 3735 (m), 3031 (w), 2957
(m), 1734 (s), 1456 (m), 1339 (m), 1267 (m), 976 (m), 732 (m), 698 (s). HRMS (ESITOF) m/z calcd for C13H20NO2 [M + H]+ 222.1494, found 222.1492.
Methyl 2-(benzyl(tert-butoxycarbonyl)amino)pentanoate S4. Triethylamine
(2.58 mL, 9.02 mmol, 2.0 equiv.) was added dropwise to a stirred solution of S3 (1.00
g, 4.51 mmol) and di-tert-butyl dicarbonate (Boc2O, 1.47 g, 6.77 mmol, 1.5 equiv.) in
dry dichloromethane (10 mL), and the reaction mixture was stirred for 24 h at room
temperature. The reaction was washed with aqueous solution of HCl (1M) (15 mL),
dried (Na2SO4), and concentrated under reduced pressure. Purification was carried out
by flash column chromatography (Et2O/hexane 1:9) to yield the N-Bn,N-Boc α-amino
ester S6. Colorless oil (0.89 g, 62%). Rf (Et2O/hexane 1:9) = 0.23. 
 = −50.4 (c
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9.5 CHCl3). 1H NMR (300 MHz, CDCl3) (mixture of rotamers) δ 0.79 (br s, 3H,
CH3), 1.24 (br s, 2H, CH2), 1.40 (br s, 4.2H, C(CH3)3), 1.45 (br s, 4.8H, C(CH3)3),
1.62-1.75 (m, 1H, CH), 1.84-1.94 (m, 1H, CH), 3.55 (s, 3H, CH3), 3.90-4.80 (m, 3H,
CH2Ph, CH), 7.19-7.28 (m, 5H, 5CHAr). 13C{1H} NMR (75 MHz, CDCl3) (mixture of
rotamers, minor rotamer indicated by asterisk) δ 13.5, 19.5, 28.1, 31.6, 32.3*, 32.4,
49.4, 50.7*, 51.5, 58.5, 59.1*, 80.2, 126.8, 127.1, 128.0, 128.3, 138.0, 138.9*, 155.6,
172.1. IR (νmax/cm-1) 3031 (w), 2961 (m), 2875 (w), 1739 (s), 1700 (s), 1452 (s), 1319
(m), 1248 (m), 1163 (m), 979 (m), 862 (m), 734 (m), 699 (s). HRMS (ESI-TOF) m/z
calcd for C18H27NO4Na [M + Na]+ 344.1838, found 344.1833.
tert-Butyl benzyl(1-hydroxypentan-2-yl)carbamate S5. To a solution of lithium
aluminum hydride (1 M solution in THF, 4.98 mL, 4.98 mmol, 2.0 equiv.) at 0 °C,
was added dropwise methyl 2-(benzyl(tert-butoxycarbonyl)amino) pentanoate S4
(0.80 g, 2.49 mmol) in THF (3 mL) and the mixture was stirred at the same
temperature for 30 min. The reaction was quenched with water (1 mL), filtered, and
concentrated under reduced pressure. The crude product was purified by flash column
chromatography (EtOAc/hexane 4:6) to obtain the corresponding α-amino alcohol
product S5 as a colorless oil (0.60 g, 82%). Rf (EtOAc/hexane 4:6) = 0.61. 
 =
+16.3 (c 4.6 CHCl3). 1H NMR (500 MHz, CDCl3) (mixture of rotamers) δ 0.84 (br s,
3H, CH3), 1.26 (br s, 2H, CH2), 1.37 (br s, 7H, C(CH3)3, CH), 1.49 (br s, 4H,
C(CH3)3, CH), 3.40-3.60 (m, 3H), 3.84-3.86 (m, 1H, CH), 4.21-4.70 (m, 2H, CH2Ph),
7.21-7.27 (m, 5H, 5CHAr).
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C{1H} NMR (125 MHz, CDCl3) (mixture of rotamers,

minor rotamer indicated by asterisk) δ 13.9, 19.7, 28.3, 30.9, 31.7*, 48.2*, 49.3, 59.2,
64.1, 80.1, 126.9, 127.6, 128.3, 139.6, 156.9. IR (νmax/cm-1) 3446 (m), 2959 (m), 2930
(m), 2873 (m), 1665 (s), 1465 (m), 1410 (s), 1341 (m), 1243 (m), 1166 (s), 1053 (w),
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701 (s). HRMS (ESI-TOF) m/z calcd for C17H27NO3Na [M + Na]+ 316.1889, found
316.1891.
tert-Butyl benzyl(1-oxopentan-2-yl)carbamate 6b. Swern oxidation of methyl
tert-butyl benzyl(1-hydroxypentan-2-yl)carbamate S5 (0.59 g, 2.01 mmol) was
carried out with oxalyl chloride (0.37 mL, 4.02 mmol, 2 equiv.), DMSO (0.61 mL,
8.04 mmol, 4 equiv.) and Et3N 4.56 mL, 32.17 mmol, 16 equiv.) in CH2Cl2 (5 mL) at
−78 °C. The reaction mixture was quenched with saturated aqueous NaHCO3 solution
(5 mL) and extracted into CH2Cl2 (3×3 mL). The combined organic layers were
washed with brine solution (10 mL), dried (Na2SO4) and concentrated under reduced
pressure to yield 6b as a colorless oil (0.50 g, 85%), which was used in the
allenylation reaction without further purification. (Caution! This reaction is carried
out at −78 °C as it has been reported that oxalyl chloride and dimethyl sulfoxide can
react explosively at room temperature. Furthermore, this procedure should be carried
out in a fumehood since a dimethyl sulfide is an odorous by-product of the reaction).32
1
Rf (EtOAc/hexane 1:9) = 0.43. 
 = −92.3 (c 7.0 CHCl3). H NMR (300 MHz,

CDCl3) (mixture of rotamers) δ 0.89 (t, 3H, J = 7.2 Hz, CH3), 1.34-1.41 (m, 2H,
CH2), 1.45 (br s, 9H, C(CH3)3), 1.49-1.80 (m, 1H, CH), 1.89-1.99 (m, 1H, CH), 3.45
(br s, 0.6H, CH), 3.76 (br s, 0.4H, CH), 4.11-4.22 (m, 1H, CHPh), 4.70 (br d, 0.4H, J
= 15.0 Hz, CHPh), 4.98 (br d, 0.6H, J = 15.0 Hz, CHPh), 7.26-7.35 (m, 5H, 5CHAr),
9.35 (br s, 0.6H, CHO), 9.44 (br s, 0.4H, CHO).
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C{1H} NMR (75 MHz, CDCl3)

(mixture of rotamers, minor rotamer indicated by asterisk) δ 13.8, 19.5, 28.1, 29.2*,
30.4, 51.4*, 51.8, 65.5, 80.9*, 81.3, 127.6, 128.3, 128.6, 137.7, 138.1*, 155.1, 199.5.
IR (νmax/cm-1) 2965 (m), 2933 (m), 2876 (w), 1739 (s), 1692 (s), 1452 (s), 1405 (s),
1365 (s), 1249 (s), 1180 (s), 1002 (m), 864 (m), 735 (s), 699 (s). HRMS (ESI-TOF)
m/z calcd for C17H25NO3Na [M + Na]+ 314.1732, found 314.1741.
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tert-Butyl benzyl(4-methyl-1-oxopentan-2-yl)carbamate (6c)
Methyl N-benzyl leucinate S6. To a stirred suspension of L-methyl leucinate
hydrochloride33 (1.0 g, 5.50 mmol) and benzyl bromide (0.7 mL, 6.05 mmol, 1.1
equiv.) in acetonitrile (20 mL), was added potassium carbonate (1.52 g, 11 mmol, 2
equiv.) and the mixture was stirred overnight at room temperature. The reaction
mixture was washed with saturated aqueous NH4Cl solution (20 mL) and water (20
mL), dried (MgSO4), concentrated under reduced pressure and purified by flash
column chromatography (Et2O/hexane 1:9) to obtain the N-benzylated product S6.
Light yellow oil (0.996 g, 77%). Data matches that reported previously.34
Methyl N-benzyl-N-(tert-butoxycarbonyl) leucinate S7. Triethylamine (0.81
mL, 2.75 mmol, 1.1 equiv.) was added dropwise to a stirred solution of S6 (1.00 g,
4.51 mmol) and di-tert-butyl dicarbonate (Boc2O, 0.67 g, 3.1 mmol, 1.24 equiv.) in
dry dichloromethane (5 mL), and the reaction mixture was stirred for 24 h at room
temperature. The reaction was washed with aqueous solution of HCl (1M) (5 mL),
dried (Na2SO4), and concentrated under reduced pressure. Purification was carried out
by flash column chromatography (Et2O/hexane 1:9) to yield the N-Bn,N-Boc α-amino
ester S7. Colorless oil (0.59 g, 70%). Data matches that previously reported.35
tert-Butyl benzyl(4-methyl-1-oxopentan-2-yl)carbamate 6c. To a solution of
S9 (0.58 g, 1.74 mmol) in dry diethyl ether (3 mL) at −78 °C, was added dropwise
diisobutylaluminum hydride (5.0 M in n-hexane, 0.70 mL, 3.49 mmol, 2 equiv.) over
45 min. The mixture was stirred at the same temperature for 1 h, and was quenched
with methanol (1 mL). The reaction mixture was allowed to warm to room
temperature, followed by adding water (2 mL). The crude mixture was filtered
through a sintered glass funnel and the filtrate was washed with brine (20 mL). The
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organic layer was dried (Na2SO4) and concentrated under reduced pressure to yield
the desired aldehyde. Colorless oil (0.35 g, 65%). Data matches that previously
reported.14d

tert-Butyl benzyl(3-methyl-1-oxobutan-2-yl)carbamate (6d)
(S)-Methyl N-benzyl-N-(tert-butoxycarbonyl) valinate S8. Triethylamine (3.32
mL, 11.56 mmol, 2 equiv.) was added dropwise to a stirred solution of (S)-methyl Nbenzyl valinate31a (1.28 g, 5.78 mmol) and di-tert-butyl dicarbonate (Boc2O, 2.14 g,
9.82 mmol, 1.7 equiv.) in dry dichloromethane (15 mL), and the reaction mixture was
stirred for 24 h at room temperature. The reaction was washed with aqueous solution
of HCl (1M) (15 mL), dried (Na2SO4), and concentrated under reduced pressure.
Purification was carried out by flash column chromatography (Et2O/hexane 1:9) to
yield the N-Bn,N-Boc α-amino ester S8. Colorless oil (1.18 g, 63%). Data matches
that previously reported.31b S8 was then converted into (S)-2-(benzylamino)-3methylbutan-1-ol as previously reported for use in the next step.31b
(S)-tert-Butylbenzyl(3-methyl-1-oxobutan-2-yl)carbamate 6d. Swern oxidation
of (S)-2-(Benzylamino)-3-methylbutan-1-ol31b (0.73 g, 2.48 mmol) was carried out
with oxalyl chloride (0.46 mL, 4.96 mmol, 2 equiv.), DMSO (0.75 mL, 9.94 mmol, 4
equiv.) and Et3N (5.63 mL, 39.68 mmol, 16 equiv.) in CH2Cl2 (5 mL) at −78 °C. The
reaction mixture was quenched with saturated aqueous NaHCO3 solution (5 mL) and
extracted into CH2Cl2 (3×3 mL). The combined organic layers were washed with
brine solution (10 mL), dried (Na2SO4) and concentrated under reduced pressure to
yield 6d as a colorless oil (0.558 g, 77%), which was used in the allenylation reaction
without further purification. Data matches that reported previously.31b
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(S)-tert-Butyl

3-(2-(benzyl(tert-butoxycarbonyl)amino)-3-oxopropyl)-1H-indole-

1-carboxylate (6f)
Methyl benzyl-L-tryptophanate S9. Methyl tryptophanate hydrochloride22b (3.60 g,
14.13 mmol) was neutralized into the free base by dissolving in diethyl ether (20 mL)
followed by treating with saturated aqueous K2CO3 solution (20 mL). The organic
layer was dried (Na2SO4) and concentrated under reduced pressure to obtain a light
yellow oil. To a stirred suspension of neutralized tryptophan methyl ester and MgSO4
(2.70 g) in dichloromethane (40 mL), was added benzaldehyde (1.43 mL, 14.13
mmol, 1 equiv.) and the mixture was stirred for 5 h at room temperature. The
resulting imine compound was dissolved in dry methanol (30 mL) and NaBH4 (0.58 g,
15.54 mmol, 1.1 equiv.) was added slowly at 0 °C. The solvent was evaporated after 1
h at 0 °C. Then the mixture was washed by NH4OH (5%, 20 mL), extracted by ethyl
acetate and dried (Na2SO4). Methyl benzyl-L-tryptophanate S9 was obtained after
flash column chromatography (EtOAc/hexane 2:8) as a colorless gummy oil (3.12 g,
72%). Data matches that reported previously.22b
Methyl

Nα-benzyl-Nα-(tert-butoxycarbonyl)-L-tryptophanate

S10.

Triethylamine (2.85 mL, 9.92 mmol, 2 equiv.) was added dropwise to a stirred
solution of methyl benzyl-L-tryptophanate S10 (1.53 g, 4.96 mmol) and di-tert-butyl
dicarbonate (1.02 g, 4.71 mmol, 0.95 equiv.) in dry dichloromethane (20 mL), and
was stirred for 24 h at room temperature. The crude reaction mixture was
concentrated under reduced pressure. Then title compound S10 was obtained after
flash column chromatography (EtOAc/hexane 2:8). Colorless gummy oil (1.37 g,
67%). Data matches that reported previously.22b
tert-Butyl

(S)-3-(2-(benzyl(tert-butoxycarbonyl)amino)-3-methoxy-3-

oxopropyl)-1H-indole-1-carboxylate S11. To a stirred solution of methyl Nα-benzyl-
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Nα-(tert-butoxycarbonyl)-L-tryptophanate S10 (1.07 g, 2.62 mmol) and di-tert-butyl
dicarbonate (0.85 g, 3.93 mmol, 1.5 equiv.) in dichloromethane (15 mL), was added
4-(dimethylamino)pyridine (0.063 g, 0.52 mmol, 0.2 equiv.) and the mixture was
stirred overnight at room temperature. The reaction mixture was diluted with EtOAc
(10 mL) and washed with water (30 mL) and saturated aqueous NaHCO3 solution (30
mL) and brine (30 mL). The organic layer was dried (Na2SO4) and the filtrate was
concentrated under reduced pressure. The title compound S11 was obtained after flash
column chromatography (EtOAc/hexane 2:9) as a colorless gummy oil (1.15 g, 86%).
1
Rf (EtOAc/hexane 2:9) = 0.48. 
 = −67.2 (c 1.0 CHCl3). H NMR (300 MHz,

CDCl3) (mixture of rotamers) δ 1.48 (s, 9H, 3CH3), 1.65 (s, 9H, 3CH3), 3.10-3.39 (m,
2H, CH2), 3.62 (s, 3H, CH3), 4.15-4.39 (m, 3H, CH2, CH), 7.01-7.42 (m, 9H, 9CHAr),
8.11 (br d, 1H, J = 6.9 Hz, CHAr). 13C NMR (75 MHz, CDCl3) (mixture of rotamers,
minor rotamer indicated by asterisk) δ 24.9*, 25.9, 28.2*, 28.3, 51.8*, 52.0, 59.6,
59.8*, 80.5*, 80.8, 83.2*, 83.4, 115.2, 115.3*, 116.5, 116.7*, 118.5, 118.7, 118.9*,
122.4, 124.00*, 124.09, 124.4, 124.3*, 126.9, 127.0, 127.1*, 127.6*, 127.9, 128.1*,
128.3, 128.5, 130.2*, 130.5, 135.4, 137.2, 137.6*, 149.5, 155.2, 171.4, 174.9*. IR
(νmax/cm-1) = 2976 (m), 2931 (m), 2357 (w), 2167 (w), 1732 (s), 1695 (s), 1452 (s),
1365 (s), 1253 (s), 1155 (s), 1083 (s), 1016 (m), 858 (m), 742 (s), 698 (s). HRMS
(ESI) m/z calcd for C29H36N2O6Na [M + Na]+ 531.2471, found 531.2492.
tert-Butyl (S)-3-(2-(N-benzylformamido)-3-methoxy-3-oxopropyl)-1H-indole1-carboxylate

6f.

To

a

solution

of

tert-butyl

3-(2-(benzyl(tert-

butoxycarbonyl)amino)-3-methoxy-3-oxopropyl)-1H-indole-1-carboxylate S11 (0.55
g, 1.08 mmol) in diethyl ether (3 mL) at −78

o

C, was added dropwise

diisobutylaluminum hydride (5.4 M in n-hexane, 0.40 mL, 2.16 mmol, 2 equiv.). The
mixture was stirred at the same temperature for 1 h, and was quenched with methanol
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(1 mL). The reaction mixture was allowed to warm to room temperature, followed by
adding water (2 mL). The crude mixture was filtered and the filtrate was washed with
brine solution (20 mL). The organic layer was dried (Na2SO4) and concentrated under
reduced pressure to yield the desired aldehyde 6f. Light orange oil (0.398 g, 77%). Rf
1
(EtOAc/hexane 2:8) = 0.63. 
 = −113.5 (c 9.8 CHCl3). H NMR (500 MHz,

CDCl3) (mixture of rotamers) δ 1.49 (s, 9H, C(CH3)3), 1.67 (s, 9H, C(CH3)3), 3.043.09 (m, 0.5H, CH), 3.29-3.31 (m, 0.5H, CH), 3.37-3.42 (m, 1H, CH), 3.52 (t, 1H, J =
16.0 Hz, CH), 3.76-3.77 (m, 1H, CHPh), 4.50 (d, 0.5H, J = 15.0 Hz, CHPh), 4.76 (d,
0.5H, J = 15.0 Hz, CHPh), 7.00 (br s, 2H, 2CHAr), 7.19-7.24 (m, 4H, 4CHAr), 7.317.41 (m, 3H, 3CHAr), 8.16 (br s, 1H, CHAr), 9.42 (s, 0.5H, CHO), 9.53 (0.5H, CHO).
13

C{1H} NMR (125 MHz, CDCl3) (mixture of rotamers, minor rotamer indicated by

asterisk) δ 22.7, 23.8*, 28.2, 28.3*, 52.0, 52.7*, 65.3, 66.0*, 81.2*, 81.8, 83.5*, 83.6,
115.4*, 115.5, 116.4, 116.7*, 118.5, 118.7*, 122.64, 122.69*, 124.2*, 124.3*, 124.5,
124.6, 127.6*, 127.75, 127.78*, 128.4, 128.63, 128.65*, 130.1, 130.4*, 135.6, 137.3,
137.5*, 149.5, 154.8, 155.3*, 198.6, 199.0*. IR (νmax/cm-1) 2978 (m), 2814 (w), 2364
(w), 2163 (w), 1730 (s), 1733 (s), 1683 (s), 1452 (s), 1365 (s), 1308 (m), 1251 (s),
1154 (s), 1085 (s), 976 (m), 856 (s), 743 (s), 700 (s). HRMS (ESI-TOF) m/z calcd for
C28H33N2O5 [M − H]+ 477.2389, found 477.2382.

(S)-Methyl N-benzyl-N-tosyl alaninate S12. The aldehyde 8 was prepared as
previously reported29 but a modified synthesis of the ester starting material required
for its synthesis was employed. Potassium carbonate (2.37 g, 17.32 mmol, 2 equiv.)
was added to a stirred solution of methyl tosyl-L-alaninate21e (2.23 g, 8.66 mmol) and
benzyl bromide (1.50 mL, 13.00 mmol, 1.5 equiv.) in acetonitrile (30 mL), and was
stirred overnight at room temperature. The reaction mixture was washed with
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saturated aqueous NH4Cl solution (50 mL) and water (50 mL), dried (MgSO4),
concentrated under reduced pressure and purified by flash column chromatography
(EtOAc/hexane 3:7) to obtain the methyl N-benzyl-N-tosyl-alaninate S13. Colorless
1
oil (2.74 g, 88%). Rf (EtOAc/hexane 3:7) = 0.54. 
 = −42.5 (c 2.5 CHCl3). H

NMR (500 MHz, CDCl3) δ 1.26-1.28 (m, 3H, CH3), 2.42 (br s, 3H, CH3), 3.42 (br s,
3H, CH3), 4.42 (br d, 1H, J = 14.5 Hz, CHPh), 4.55 (br d, 1H, J = 16.0 Hz, CHPh),
4.61-4.63 (m, 1H, CH), 7.23-7.32 (m, 7H, 7CHAr), 7.71 (br d, 2H, J = 5.5 Hz, 2CHAr).
13

C{1H} NMR (125 MHz, CDCl3) δ 16.4, 21.5, 49.1, 52.0, 55.0, 127.4, 127.5, 128.0,

128.3, 129.5, 137.1, 137.3, 143.4, 171.6. IR (νmax/cm-1) 2950 (w), 1742 (s), 1456 (m),
1339 (s), 1152 (s), 1089 (m), 845 (m), 725 (s), 655 (s). HRMS (ESI-TOF) m/z calcd
for C18H21NO4NaS [M + Na]+ 370.1089, found 370.1073.

General Procedure A. Allenylation of Chiral N-Boc α-Amino Aldehydes and
Subsequent Base-Catalyzed Cyclization. To a solution of allenylboronic acid
pinacol ester 1 (1.1 equiv.) and the amino aldehydes 2a-2f in toluene at 0 °C, was
added Et2Zn (1 M in toluene, 10 mol%) under nitrogen. The suspension was then
stirred at 0 °C for 18 h. The reaction mixture was quenched with saturated aqueous
NH4Cl solution, and washed with saturated aqueous NaHCO3 solution (15 mL) and
water (10 mL). The organic layer was dried (Na2SO4), concentrated under reduced
pressure and purified by flash column chromatography (EtOAc/hexane) to afford the
allenyl amino alcohol products 9a-9f. To a solution of the allenyl product in dry THF
was added sodium hydride (60% in mineral oil, 2.0 equiv.) at 0 °C and the reaction
mixture was stirred at room temperature for 90 min. The reaction mixture was
quenched by saturated aqueous NH4Cl solution, washed with water (10 mL), dried
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(MgSO4), and then purified by flash column chromatography (acetone/n-pentane) to
afford the corresponding oxazolidinone products 23a-23f.

tert-Butyl ((2S,3S)-3-hydroxyhexa-4,5-dien-2-yl)carbamate (9a). The title
compound 9a was obtained after flash column chromatography (EtOAc/hexane 3:7)
as a 2.6:1 mixture of syn and anti diasteresomers following the general procedure A
using tert-butyl (1-oxopropan-2-yl)carbamate 2a (0.06 g, 0.34 mmol), allenylboronic
acid pinacol ester 1 (69.0 µL, 0.37 mmol, 1.1 equiv.) and Et2Zn (1 M in toluene, 35.7
µL, 0.034 mmol, 10 mol%) in dry toluene (1 mL). Yellow oil (0.067 g, 92%). Rf
(EtOAc/hexane 3:7) = 0.36. 1H NMR (500 MHz, CDCl3) (mixture of two allene
diastereomers, relative integrations given for each diastereomer) δ 1.12 (d, 3H, J = 6.5
Hz, CH3, minor isomer), 1.19 (d, 3H, J = 7.0 Hz, CH3, major isomer), 1.44 (s, 9H,
C(CH3)3, for each isomer), 2.87 (br s, 1H, OH, major isomer), 3.17 (br s, 1H, OH,
minor isomer), 3.71-3.75 (m, 1H, CH, major isomer), 3.75-3.82 (m, 1H, CH, minor
isomer), 4.09 (br s, 1H, CH, major isomer), 4.23 (br s, 1H, CH, minor isomer), 4.864.90 (m, 2H, CH2=C=, for each isomer), 5.16-5.28 (m, 1H, CH=C=, for each isomer).
13

C{1H} NMR (125 MHz, CDCl3) (mixture of two allene diastereomers, minor

indicated by asterisk) δ 18.8, 19.9, 20.1, 28.3, 29.8, 30.0*, 60.4, 60.8*, 69.3, 69.4*,
76.8, 79.1, 79.2*, 90.7*, 93.0, 156.6, 156.7*, 207.4, 207.9*. IR (νmax/cm-1) 3378 (w),
2976 (w), 1955 (w), 1683 (s), 1506 (m), 1365 (m), 1257 (m), 1162 (s), 1051 (s), 1024
(s). HRMS (ESI-TOF) m/z calcd for C11H18NO3 [M − H]+ 212.1287, found 212.1289.

(4S,5S)-4-Methyl-5-(propa-1,2-dien-1-yl)oxazolidin-2-one (23a). The title
compound 23a was obtained as a single diastereomer following the general procedure
A using 9a (0.060 g, 0.28 mmol) and sodium hydride (60% in mineral oil, 18.81 mg,
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0.56 mmol, 2.0 equiv.) in THF (1 mL). Colorless oil (0.024 g, 61%). Rf (2%
1
CH2Cl2/Et2O) = 0.52. 
 = −30.3 (c 1.2 CHCl3). H NMR (500 MHz, CDCl3) δ

1.28 (d, 3H, J = 6.0 Hz, CH3), 3.75-3.80 (m, 1H, CH), 4.55 (t, 1H, J = 6.5, 7.0 Hz,
CH), 4.93-5.00 (m, 2H, CH2=C=), 5.32 (q, 1H, J = 7.0 Hz, CH=C=), 6.02 (br s, 1H,
NH).

13

C{1H} NMR (125 MHz, CDCl3) δ 20.0, 54.0, 78.6, 81.6, 89.0, 158.9, 209.2.

IR (νmax/cm-1) 3272 (m), 2926 (w), 1955 (w), 1739 (s), 1378 (m), 1003 (s), 942 (s),
855 (s), 770 (m). HRMS (ESI-TOF) m/z calcd for C7H9NO2Na [M + Na]+ 162.0531,
found 162.0537.

tert-Butyl ((4S,5S)-5-hydroxyocta-6,7-dien-4-yl)carbamate (9b). The title
compound 9b was obtained after flash column chromatography (EtOAc/hexane 2:8)
as a 5.2:1 mixture of syn and anti diastereomers following the general procedure A
using tert-butyl(1-oxopentan-2-yl)carbamate 2b (0.149 g, 0.74 mmol), allenylboronic
acid pinacol ester 1 (155.6 µL, 0.81 mmol, 1.1 equiv.) and Et2Zn (1 M in toluene,
79.17 µL, 0.074 mmol, 10 mol%) in dry toluene (2 mL). Colorless oil (0.145 g,
81%). Rf (EtOAc/hexane 2:8) = 0.45. 1H NMR (500 MHz, CDCl3) (mixture of two
allene diastereomers, relative integrations given for each diastereomer) δ 0.92 (t, 3H,
J = 7.0 Hz, CH3, for each isomer), 1.31-1.40 (m, 3H, CH and CH2, for each isomer),
1.43 (s, 9H, C(CH3)3, for each isomer), 1.50-1.56 (m, H, CH, for each isomer), 3.00
(br s, 1H, OH, minor isomer), 3.17 (br s, 1H, OH, major isomer), 3.59 (br s, 1H, CH,
major isomer), 3.70-3.73 (m, 1H, CH, minor isomer), 4.16 (br s, 1H, CH, major
isomer), 4.23 (br s, 1H, CH, minor isomer), 4.85-4.90 (m, 2H, CH2=C=, major
isomer), 4.94-4.96 (m, 2H, CH2=C=, minor isomer), 5.18-5.27 (m, 1H, CH=C=, for
each isomer).

13

C{1H} NMR (125 MHz, CDCl3) (mixture of two allene

diastereomers, minor indicated by asterisk) δ 13.9, 19.3, 28.3, 34.0, 34.2*, 54.9,
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55.2*, 70.2*, 71.4, 77.3, 79.2, 79.4*, 90.5*, 92.3, 156.4, 156.5*, 207.6. IR (νmax/cm-1)
3380 (m), 2959 (m), 1955 (m), 1683 (s), 1506 (s), 1365 (s), 1248 (s), 1166 (s), 1055
(s), 1018 (s), 843 (s). HRMS (ESI-TOF) m/z calcd for C13H23NO3Na [M + Na]+
264.1576, found 264.1573.

(4S,5S)-5-(Propa-1,2-dien-1-yl)-4-propyloxazolidin-2-one (23b). The title
compound 23b was obtained as s single diastereomer after column chromatography
(acetone/n-pentane 2:8) following the general procedure A using 9b (0.067 g, 0.28
mmol) and sodium hydride (60% in mineral oil, 18.81 mg, 0.56 mmol, 2.0 equiv.) in
THF (1 mL). Colorless oil (0.026 g, 55%). Rf (acetone/n-pentane 2:8) = 0.45. 
 =
−24.9 (c 1.3 CHCl3). 1H NMR (500 MHz, CDCl3) δ 0.95 (t, 3H, J = 7.0, 7.5 Hz,
CH3), 1.32-1.43 (m, 2H, CH2), 1.54-1.57 (m, 2H, CH2), 3.67 (q, 1H, J = 6.5 Hz, CH),
4.62-4.65 (m, 1H, CH), 4.96-4.99 (m, 2H, CH2=C=), 5.34 (q, 1H, J = 6.5, 7.0 Hz,
CH=C=), 6.51 (br s, 1H, NH).

13

C{1H} NMR (125 MHz, CDCl3) δ 73.7, 78.6, 96.7,

117.8, 138.4, 140.0, 149.4, 219.0, 268.8. IR (νmax/cm-1) 3266 (m), 2959 (m), 2932
(m), 1955 (m), 1742 (s), 1387 (s), 1239 (s), 1239 (s), 978 (s), 852 (s), 767 (s). HRMS
(ESI-TOF) m/z calcd for C9H12NO2 [M − H]+ 166.0862, found 166.0870.

tert-Butyl ((4S,5S)-5-hydroxy-2-methylocta-6,7-dien-4-yl)carbamate (9c).
The title compound 9c was obtained after flash column chromatography
(EtOAc/hexane 2:8) as a 5.7:1 mixture of syn and anti diastereomers following the
general procedure A using tert-butyl (4-methyl-1-oxopentan-2-yl)carbamate 2c (0.18
g, 0.83 mmol), allenylboronic acid pinacol ester 1 (176.56 µL, 0.92 mmol, 1.1 equiv.)
and Et2Zn (1 M in toluene, 88.80 µL, 0.083 mmol, 10 mol%) in dry toluene (2 mL).
White solid (0.172 g, 81%). Mp = 38-40 °C. Rf (EtOAc/hexane 2:8) = 0.37. 1H NMR
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(500 MHz, CDCl3) (mixture of two allene diastereomers, relative integrations given
for each diastereomer) δ 0.92 (d, 6H, J = 6.0 Hz, 2CH3, for each isomer), 1.27-1.39
(m, 1H, CH, for each isomer), 1.43 (s, 9H, C(CH3)3, for each isomer), 1.65-1.68 (m,
2H, CH2, for each isomer), 3.11 (br s, 1H, OH, major isomer), 2.95 (br s, 1H, OH,
minor isomer), 3.68 (br s, 1H, CH, major isomer), 3.70-3.80 (br s, 1H, CH, minor
isomer), 4.12 (br s, 1H, CH, major isomer), 4.22 (br s, 1H, CH, minor isomer), 4.794.90 (m, 2H, CH2=C=, for each isomer), 5.18-5.20 (m, 1H, CH=C=, minor isomer),
5.25-5.27 (m, 1H, CH=C=, major isomer).

13

C{1H} NMR (125 MHz, CDCl3)

(mixture of two allene diastereomers, minor indicated by asterisk) δ 22.0*, 23.2, 24.8,
28.3, 40.8, 41.3*, 53.2, 53.9*, 71.7, 72.5*, 76.8, 79.2, 79.7*, 91.2*, 92.3, 156.3,
156.5*, 207.6. IR (νmax/cm-1) 3361 (m), 2956 (m), 1955 (m), 1682 (s), 1504 (s), 1365
(s), 1248 (s), 1166 (s), 1047 (s), 843 (s). HRMS (ESI-TOF) m/z calcd for
C14H25NO3Na [M + Na]+ 278.1732, found 278.1720.
(4S,5S)-4-Isobutyl-5-(propa-1,2-dien-1-yl)oxazolidin-2-one (23c). The title
compound 23c was obtained as s single diastereomer after column chromatography
(acetone/n-pentane 2:8) following the general procedure A using 9c (0.05 g, 0.195
mmol) and sodium hydride (60% in mineral oil, 18.81 mg, 0.39 mmol, 2.0 equiv.) in
THF (1 mL). Colorless oil (0.021 g, 58%). Rf (acetone/n-pentane 2:8) = 0.30. 
 =
−32.6 (c 1 CHCl3). 1H NMR (500 MHz, CDCl3) δ 0.91-0.93 (m, 6H, 2CH3), 1.381.43 (m, 1H, CH), 1.48-1.53 (m, 1H, CH), 1.61-1.68 (m, 1H, CH), 3.70-3.74 (m, 1H,
CH), 4.58-4.61 (m, 1H, CH), 4.93-5.00 (m, 2H, CH2=C=), 5.33 (q, 1H, J = 6.5 Hz,
CH=C=), 6.28 (br s, 1H, NH).

13

C{1H} NMR (125 MHz, CDCl3) δ 22.2, 23.1, 25.2,

44.1, 56.5, 78.6, 80.5, 89.5, 159.1, 209.1. IR (νmax/cm-1) 3256 (m), 2962 (m), 1956
(w), 1742 (s), 1387 (m), 1228 (m), 993 (m), 852 (m), 734 (m). HRMS (ESI-TOF) m/z
calcd for C10H15NO2Na [M + Na]+ 204.0995, found 204.0996.
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tert-Butyl

((3S,4S)-4-hydroxy-2-methylhepta-5,6-dien-3-yl)carbamate

(9d). The title compound 9d was obtained after flash column chromatography
(EtOAc/hexane 2:8) as a 9:1 mixture of syn and anti diastereomers following the
general procedure A using tert-butyl (3-methyl-1-oxobutan-2-yl)carbamate 2d (0.10
g, 0.496 mmol), allenylboronic acid pinacol ester 1 (103.75 µL, 0.54 mmol, 1.1
equiv.) and Et2Zn (1 M in toluene, 37.14 µL, 0.035 mmol, 7 mol%) in dry toluene (1
mL). White solid (0.106 g, 88%). Mp = 39-41 °C. Rf (EtOAc/hexane 2:8) = 0.35. 1H
NMR (500 MHz, CDCl3) (mixture of two allene diastereomers, relative integrations
given for each diastereomer) δ 0.94 (d, 3H, J = 6.5 Hz, CH3, for each isomer), 0.99 (d,
3H, J = 6.5 Hz, CH3, for each isomer), 1.44 (s, 9H, C(CH3)3, for each isomer), 1.871.93 (m, 1H, CH, for each isomer), 2.68 (br s, 1H, OH, minor isomer), 2.80 (br s, 1H,
OH, major isomer), 3.20-3.23 (m, 1H, CH, minor isomer), 3.26-3.29 (m, 1H, CH,
major isomer), 4.28 (br s, 1H, CH, minor isomer), 4.33 (br s, 1H, CH, major isomer),
4.85-4.93 (m, 2H, CH2=C=, for each isomer), 5.19-5.21 (m, 1H, CH=C=, minor
isomer), 5.25-5.26 (m, 1H, CH=C=, major isomer).

13

C{1H} NMR (125 MHz,

CDCl3) (mixture of two allene diastereomers, minor indicated by asterisk) δ 18.8,
19.9, 20.1, 28.3, 29.8, 30.0*, 60.4, 60.8*, 69.3, 69.4*, 76.8, 79.1, 79.2*, 90.7*, 93.0,
156.6, 156.7*, 207.4, 207.9*. IR (νmax/cm-1) 3373 (m), 2979 (m), 2361 (m), 1955 (w),
1662 (s), 1525 (s), 1367 (s), 1245 (s), 1166 (s), 1018 (m), 869 (m), 684 (m). HRMS
(ESI-TOF) m/z calcd for C13H23NO3Na [M + Na]+ 264.1576, found 264.1581.

(4S,5S)-4-Isopropyl-5-(propa-1,2-dien-1-yl)oxazolidin-2-one

(23d).

The

title compound 23d was obtained as a 4.3:1 mixture of two diastereomers after
column chromatography (acetone/n-pentane 2:8) following the general procedure A

30

using 9d (0.10 g, 0.414 mmol) and sodium hydride (60% in mineral oil, 27.88 mg,
0.83 mmol, 2.0 equiv.) in THF (1 mL). Milky oil (0.106 g, 74%). Rf (acetone/npentane 2:8) = 0.44. 1H NMR (500 MHz, CDCl3) (mixture of two diastereomers,
relative integrations given for each diastereomer) δ 0.94 (br d, 3H, J = 6.5 Hz, CH3,
major isomer), 0.98 (br d, 3H, J = 6.0 Hz, CH3, major isomer), 0.99 (br d, 3H, J = 6.0
Hz, CH3, minor isomer), 1.77 (br s, 1H, CH, major isomer), 1.90 (br s, 1H, CH, minor
isomer), 3.45 (br s, 1H, CH, major isomer), 3.61-3.63 (m, 1H, CH, major isomer),
4.74 (br s, 1H, CH, major isomer), 4.92-4.97 (m, 2H, CH2=C=, for each isomer),
5.04-5.06 (m, 1H, CH, minor isomer), 5.32-5.37 (m, 1H, CH=C=, for each isomer),
6.58 (br s, 1H, NH, minor isomer), 6.66 (br s, 1H, NH, major isomer). 13C{1H} NMR
(125 MHz, CDCl3) (mixture of two diastereomers, minor indicated by asterisk) δ
17.93, 17.97, 28.1*, 32.3, 62.3*, 63.5, 75.5*, 78.0, 78.6, 78.7*, 85.9*, 90.4, 159.1,
159.8*, 208.7, 210.0*. IR (νmax/cm-1) 3260 (m), 2963 (m), 1955 (w), 1743 (s), 1387
(m), 1228 (m), 993 (m), 851 (m), 734 (m). HRMS (ESI-TOF) m/z calcd for
C9H13NO2Na [M + Na]+ 190.0838, found 190.0840.

tert-Butyl ((2S,3S)-3-hydroxy-1-phenylhexa-4,5-dien-2-yl)carbamate (9e).
The title compound 9e was obtained after flash column chromatography
(EtOAc/hexane 3:7) as a 2.5:1 mixture of syn and anti diastereomers following the
general procedure A using tert-butyl (1-oxo-3-phenylpropan-2-yl)carbamate 2e
(0.093 g, 0.373 mmol), allenylboronic acid pinacol ester 1 (78.78 µL, 0.41 mmol, 1.1
equiv.) and Et2Zn (1 M in toluene, 40.00 µL, 0.0373 mmol, 10 mol%) in dry toluene
(1 mL). White solid (0.087 g, 80%). Mp = 60-62 °C. Rf (EtOAc/hexane 3:7) = 0.53.
1

H NMR (500 MHz, CDCl3) (mixture of two allene diastereomers, relative

integrations given for each diastereomer) δ 1.36 (s, 9H, C(CH3)3, minor isomer), 1.43
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(s, 9H, C(CH3)3, major isomer), 2.61 (br s, 1H, OH, major isomer), 2.88-2.96 (m, 2H,
CH2Ph, for each isomer), 3.76 (br s, 1H, CH, minor isomer), 3.82 (br s, 1H, CH,
major isomer), 4.15 (br s, 1H, CH, major isomer), 4.27 (br s, 1H, CH, minor isomer),
4.85-4.91 (m, 2H, CH2=C=, for each isomer), 5.24-5.29 (m, 1H, CH=C=, for each
isomer), 7.19-7.29 (m, 5H, 5CHAr, for each isomer).

13

C{1H} NMR (125 MHz,

CDCl3) (mixture of two allene diastereomers, minor indicated by asterisk) δ 28.5,
36.1*, 38.2, 56.1*, 56.4, 69.4, 77.9*, 78.0, 79.4, 79.8*, 91.2*, 92.6, 126.3*, 126.6,
128.4, 129.2*, 129.32*, 129.37, 138.0*, 138.2, 156.0, 207.4*, 207.6. IR (νmax/cm-1)
3379 (m), 2981 (w), 2358 (s), 1954 (w), 1675 (s), 1521 (s), 1452 (m), 1248 (s), 1168
(s), 1002 (m), 837 (s), 759 (m), 703 (s). HRMS (ESI-TOF) m/z calcd for C17H24NO3
[M + H]+ 290.1756, found 290.1751.

(4S,5S)-4-Benzyl-5-(propa-1,2-dien-1-yl)oxazolidin-2-one (23e). The title
compound 23e was obtained as a 3:1 mixture of two diastereomers after column
chromatography (acetone/n-pentane 2:8) following the general procedure A using 9e
(0.087 g, 0.30 mmol) and sodium hydride (60% in mineral oil, 20.16 mg, 0.60 mmol,
2.0 equiv.) in THF (1 mL). Colorless oil (0.041 g, 63%). Rf (acetone/n-pentane 2:8) =
0.31.

1

H NMR (500 MHz, CDCl3) (mixture of two diastereomers, relative

integrations given for each diastereomer) δ 2.70-2.75 (m, 2H, CH2Ph, minor isomer),
2.86-2.90 (m, 2H, CH2Ph, major isomer), 3.90 (q, 1H, J = 6.5 Hz, CH, major isomer),
4.10-4.14 (m, 1H, CH, minor isomer), 4.72 (t, 1H, J = 6.0 Hz, CH, major isomer),
4.84-4.93 (m, 2H, CH2=C=, major isomer), 4.96-4.98 (m, 2H, CH2=C=, minor
isomer), 5.13 (t, 1H, J = 8.0 Hz, CH, minor isomer), 5.24 (q, 1H, J = 6.5, 7.0 Hz,
CH=C=, major isomer), 5.35 (q, 1H, J = 7.0 Hz, CH=C=, minor isomer), 5.65 (br s,
1H, NH, minor isomer), 6.19 (br s, 1H, NH, major isomer), 7.16 (d, 2H, J = 7.5 Hz,
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2CHAr, for each isomer), 7.22-7.25 (m, 1H, CHAr, for each isomer), 7.29-7.32 (m, 2H,
2CHAr, for each isomer).

13

C{1H} NMR (125 MHz, CDCl3) (mixture of two

diastereomers, minor indicated by asterisk) δ 37.5*, 40.9, 57.5*, 59.3, 78.0*, 78.3*,
78.7, 79.3, 86.3*, 89.5, 127.33, 127.39*, 129.10, 129.18*, 129.2*, 129.4, 136.0,
136.9*, 158.7, 209.0, 210.0*. IR (νmax/cm-1) 3267 (w), 2917 (w), 1955 (w), 1743 (s),
1386 (m), 1230 (m), 992 (s), 854 (s), 699 (s). HRMS (ESI-TOF) m/z calcd for
C13H13NO2Na [M + Na]+ 238.0838, found 238.0840.

tert-Butyl

3-((2S,3S)-2-((tert-butoxycarbonyl)amino)-3-hydroxyhexa-4,5-

dien-1-yl)-1H-indole-1-carboxylate (9f). The title compound 9f was obtained after
flash column chromatography (EtOAc/hexane 2:8) as a 2.5:1 mixture of syn and anti
diastereomers following the general procedure A using tert-butyl 3-(2-((tertbutoxycarbonyl)amino)-3-oxopropyl)-1H-indole-1-carboxylate 2f (0.05 g, 0.128
mmol), allenylboronic acid pinacol ester 1 (27.00 µL, 0.14 mmol, 1.1 equiv.) and
Et2Zn (1 M in toluene, 14.00 µL, 0.0128 mmol, 10 mol%) in dry toluene (1 mL).
Colorless oil (0.043 g, 78%). Rf (EtOAc/hexane 2:8) = 0.33. 1H NMR (500 MHz,
CDCl3) (mixture of two allene diastereomers, relative integrations given for each
diastereomer) δ 1.39 (s, 9H, C(CH3)3, minor isomer), 1.42 (s, 9H, C(CH3)3, major
isomer), 1.65 (s, 9H, C(CH3)3, for each isomer), 2.52 (br s, 1H, OH, major isomer),
2.91-3.06 (m, 2H, CH2, for each isomer), 3.93 (br s, 1H, CH, major isomer), 4.06 (br
s, 1H, CH, minor isomer), 4.23 (br s, 1H, CH, major isomer), 4.32 (br s, 1H, CH,
minor isomer), 4.87-5.04 (m, 2H, CH2=C=, for each isomer), 5.26-5.32 (m, 1H,
CH=C=, for each isomer), 7.22-7.66 (m, 4H, 4CHAr, for each isomer), 8.13 (br s, 1H,
CHAr, for each isomer).

13

C{1H} NMR (125 MHz, CDCl3) (mixture of two allene

diastereomers, minor indicated by asterisk) δ 28.2, 28.3*, 54.7, 55.3*, 69.3, 71.7*,
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78.1*, 78.3, 79.5, 79.8*, 83.5, 91.3*, 92.6, 115.21, 115.27*, 116.8*, 117.0, 119.0,
119.2*, 122.5, 123.9, 124.41, 124.46*, 130.7, 135.4, 149.7, 156.1, 207.4, 207.5*. IR
(νmax/cm-1) 3385 (w), 2975 (w), 2930 (w), 1955 (w), 1730 (s), 1684 (s), 1507 (m),
1452 (s), 1367 (s), 1252 (s), 1157 (s), 1085 (s), 1015 (m), 852 (m), 744 (s). HRMS
(ESI-TOF) m/z calcd for C24H32N2O5Na [M + Na]+ 451.2209, found 451.2227.

tert-Butyl

3-(((4R,5R)-2-oxo-5-(propa-1,2-dien-1-yl)oxazolidin-4-

yl)methyl)-1H-indole-1-carboxylate (23f). The title compound 23f was obtained as a
single diastereomer after careful column chromatography (acetone/n-pentane 2:8)
following the general procedure A using 9f (0.036 g, 0.084 mmol) and sodium
hydride (60% in mineral oil, 5.68 mg, 0.168 mmol, 2.0 equiv.) in THF (1 mL).
Colorless gummy oil (0.015 g, 50%). Rf (acetone/n-pentane 2:8) = 0.26. 
 =
−35.8 (c 0.7 CHCl3). 1H NMR (500 MHz, CDCl3) δ 1.68 (s, 9H, C(CH3)3), 2.90-2.94
(m, 1H, CH), 3.00-3.04 (m, 1H, CH), 4.03 (br s, 1H, CH), 4.81 (br s, 1H, CH), 4.96
(br s, 2H, CH2=C=), 5.19 (br s, 1H, NH), 5.37 (br d, 1H, J = 6.5 Hz, CH=C=), 7.26
(br s, 1H, CHAr), 7.34-7.37 (m, 1H, CHAr), 7.46 (br s, 2H, 2CHAr), 8.15 (br s, 1H,
CHAr).

13

C{1H} NMR (125 MHz, CDCl3) δ 28.2, 30.5, 57.5, 78.8, 79.4, 84.0, 89.2,

114.9, 115.5, 118.5, 122.8, 123.9, 124.9, 129.7, 135.6, 149.4, 157.7, 208.8. IR
(νmax/cm-1) 3277 (w), 2982 (w), 2357 (w), 1955 (w), 1751 (s), 1730 (s), 1452 (s), 1368
(s), 1255 (s), 1155 (s), 1086 (m), 854 (m). HRMS (ESI-TOF) m/z calcd for
C20H23N2O4 [M + H]+ 355.1658, found 355.1664.

(2S,3S)-2-(Tritylamino)hexa-4,5-dien-3-ol (12). The title compound 12 was
obtained after flash column chromatography (Et2O/hexane 2:8) as a 1.3:1 mixture of
syn and anti diastereomers following the general procedure A using 2-
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(tritylamino)propanal 5 (0.10 g, 0.317 mmol), allenylboronic acid pinacol ester 1
(78.00 µL, 0.41 mmol, 1.1 equiv.) and Et2Zn (1 M in toluene, 34.0 µL, 0.0317 mmol,
10 mol%) in dry toluene (1 mL). Colorless oil (0.093 g, 82%). Rf (Et2O/hexane 2:8)
= 0.41. 1H NMR (300 MHz, CDCl3) (mixture of two allene diastereomers, relative
integrations given for each diastereomer) δ 0.43 (d, 3H, J = 6.0 Hz, CH3, minor
isomer), 0.75 (d, 3H, J = 6.6 Hz, CH3, major isomer), 2.23 (br s, 1H, NH, for each
isomer), 2.69-2.77 (m, 1H, CH, for each isomer), 3.40-3.43 (m, 1H, CH, for each
isomer), 4.74-4.77 (m, 2H, CH2=C, major isomer), 4.80-4.83 (m, 2H, CH2=C, minor
isomer), 4.98 (q, 1H, J = 6.0, 6.3 Hz, CH=C, major isomer), 5.22 (q, 1H, J = 6.6, 6.6
Hz, CH=C, minor isomer), 7.15-7.28 (m, 10H, 10CHAr, for each isomer), 7.54 (d, 5H,
J = 7.8 Hz, 5CHAr, for each isomer).

13

C{1H} NMR (75 MHz, CDCl3) (mixture of

two allene diastereomers, minor indicated by asterisk) δ 15.9, 17.1*, 52.6, 53.0*,
71.2, 71.3*, 73.2*, 76.6, 91.7*, 92.2, 126.4, 127.9, 128.7, 128.8*, 146.73, 146.76*,
207.1, 207.9*. IR (νmax/cm-1) 3385 (w), 3056 (w), 2970 (w), 1952 (m), 1490 (s), 1447
(s), 1031 (s), 845 (s), 744 (s), 705 (s). HRMS (ESI-TOF) m/z calcd for C25H26NO [M
+ H]+ 356.2014, found 356.2011.

General Procedure B. Allenylation of Chiral N,N-[((tert-butoxy)carbonyl)benzyl]
amino aldehydes and Subsequent Gold-Catalyzed Cyclization. To a solution of
allenylboronic acid pinacol ester 1 (1.3 equiv.) and the amino aldehydes 6a-g in
toluene at 0 °C, was added Et2Zn (1 M in toluene, 10 mol%) under nitrogen. The
suspension was then stirred at 0 °C for 18 h. The reaction mixture was quenched with
saturated aqueous NH4Cl solution (5 mL), and then washed with saturated aqueous
NaHCO3 solution (15 mL) and water (10 mL). The organic layer was dried (Na2SO4),
and then concentrated under reduced pressure to afford the resulting allenyl amino
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alcohol product 13. Then, to a solution of this crude product in dry dichloroethane
was added AuPPh3NTf2 (10 mol%). The reaction was stirred at 60 °C for 8 h and then
filtered through a pad of silica gel and after removal of the solvent the crude product
was used in the next step without purification. Chlorotrimethylsilane (5 equiv.) was
added to a solution of the crude dihydrofuran in dry methanol. The reaction mixture
was stirred at room temperature overnight, and then was neutralized by the addition of
saturated aqueous NaHCO3 solution to about pH = 7, followed by purification by flash
column chromatography to afford the corresponding Boc-deprotected dihydrofuran
products 25a-25g.

tert-Butyl

benzyl((2S,3R)-3-hydroxyhexa-4,5-dien-2-yl)carbamate

(13).

The title compound 13 was prepared following the first part of general procedure B
(in this case was purified by column chromatography as part of the optimization
study) using tert-butyl benzyl(1-oxopropan-2-yl)carbamate 6a (0.065 g, 0.24 mmol),
allenylboronic acid pinacol ester 1 (61 µL, 0.32 mmol, 1.3 equiv.) and Et2Zn (1 M in
toluene, 25 µL, 0.024 mmol, 10 mol%) in dry toluene (2 mL). The crude product was
purified by flash column chromatography (EtOAc/hexane 2:8) as a 19:1 mixture of
anti and syn diastereomers. Colorless oil (0.07 g, 96%). Rf (EtOAc/hexane 2:8) =
1
0.31. 
 = +7.31 (c 7.2 CH3Cl). H NMR (500 MHz, CDCl3) (mixture of rotamers)

δ 1.17 (d, 0.7H, J = 7.0 Hz), 1.20 (d, 2.3H, J = 7.0 Hz), 1.33-1.45 (br s, 9H, C(CH3)3),
3.70-3.76 (m, 1H, CH), 4.01-4.12 (m, 0.7H), 4.35-4.49 (m, 3.3H), 4.80 (m, 2H,
CH2=C=), 5.12-5.17 (m, 1H, CH=C=), 7.23-7.33 (m, 5H, 5CHAr).

13

C{1H} NMR

(125 MHz, CDCl3) (mixture of rotamers, minor rotamer indicated by asterisk) δ 11.9,
28.3, 51.1, 58.5*, 58.7, 72.9, 77.4, 80.6, 80.6*, 92.8, 127.0, 127.1, 127.3*, 128.4,
128.5*, 139.1, 156.7, 207.1. IR (νmax/cm-1) 3473 (m), 2976 (m), 1956 (m), 1680 (s),
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1452 (s), 1365 (s), 1332 (m), 1250 (m), 1164 (s), 1012 (s), 860 (s), 699 (s). HRMS
(ESI-TOF) m/z calcd for C18H25NO3Na [M + Na]+ 326.1721, found 326.1731.

N-Benzyl-N-((2S,3R)-3-hydroxyhexa-4,5-dien-2-yl)-4methylbenzenesulfonamide (14). The major diastereomer of the title compound 14
was obtained after purification by flash column chromatography (EtOAc/hexane 3:7)
following the first pat of general procedure B using N-benzyl-4-methyl-N-(1oxopropan-2-yl)benzenesulfonamide 7 (0.072 g, 0.226 mmol), allenylboronic acid
pinacol ester 1 (56.50 µL, 0.29 mmol, 1.3 equiv.) and Et2Zn (1 M in toluene, 24.00
µL, 0.0226 mmol, 10 mol%) in dry toluene (1 mL). Colorless oil (0.044 g, 54%). Rf
1
(EtOAc/hexane 3:7) = 0.44. 
 = +35.2 (c 2.5 CHCl3). H NMR (500 MHz,

CDCl3) δ 1.01 (d, 3H, J = 7.0 Hz, CH3), 1.84 (d, 1H, J = 4.0 Hz, OH), 2.42 (s, 3H,
CH3), 3.88-3.91 (m, 1H, CH), 4.03 (br s, 1H, CH), 4.27 (d, 1H, J = 15.5 Hz, CHPh),
4.60 (d, 1H, J = 16.0 Hz, CHPh), 4.78-4.80 (m, 2H, CH2=C=), 5.15 (q, 1H, J = 6.5,
6.5 Hz, CH=C=), 7.23-7.31 (m, 5H, 5CHAr), 7.37 (d, 2H, J = 7.5 Hz, 2CHAr), 7.69 (d,
2H, J = 8.5 Hz, 2CHAr).

13

C{1H} NMR (125 MHz, CDCl3) δ 12.4, 21.5, 48.5, 58.6,

71.8, 78.3, 93.0, 127.1, 127.5, 128.2, 128.5, 129.7, 137.7, 137.9, 143.3, 207.0. IR
(νmax/cm-1) 3502 (m), 2984 (w), 2922 (w), 1954 (m), 1598 (m), 1333 (s), 1150 (s),
1088 (s), 1002 (s), 863 (S), 732 (s), 657 (s). HRMS (ESI-TOF) m/z calcd for
C20H23NO3NaS [M + Na]+ 380.1296, found 380.1285.

(2S,3R)-2-(Dibenzylamino)hexa-4,5-dien-3-ol (15). The major diastereomer
of the title compound 15 was obtained after purification by flash column
chromatography (Et2O/hexane 1:9) following the general procedure B using 2(dibenzylamino)propanal 8 (0.096 g, 0.339 mmol), allenylboronic acid pinacol ester 1
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(84.00 µL, 0.44 mmol, 1.3 equiv.) and Et2Zn (1 M in toluene, 36.00 µL, 0.0339 mmol,
10 mol%) in dry toluene (1 mL). Colorless oil (0.05 g, 50%). Rf (Et2O/hexane 1:9) =
1
0.25. 
 = -36.2 (c 4.1 CHCl3). H NMR (500 MHz, CDCl3) δ 1.12 (d, 3H, J =

11.5 Hz, CH3), 2.85-2.89 (m, 1H, CH), 3.42 (d, 2H, J = 23.0 Hz, 2CHPh), 3.82 (d,
2H, J = 23.0 Hz, 2CHPh), 4.07-4.12 (m, 1H, CH), 4.77-4.81 (m, 2H, CH2=C=), 5.30
(q, 1H, J = 10.5, 10.5 Hz, CH=C=), 7.19-7.34 (m, 10H, 10CHAr). 13C{1H} NMR (125
MHz, CDCl3) δ 9.2, 54.9, 57.7, 71.1, 76.8, 93.6, 127.2, 128.5, 129.0, 139.9, 207.6. IR
(νmax/cm-1) 3379 (w), 3027 (w), 2926 (w), 2801 (w), 1952 (m), 1452 (m), 1368 (m),
1244 (w), 1027 (s), 845 (s), 744 (s), 696 (s). HRMS (ESI-TOF) m/z calcd for
C20H24NO [M + H]+ 294.1858, found 294.1852.

(4S,5R)-3-Benzyl-4-methyl-5-(propa-1,2-dien-1-yl)oxazolidin-2-one

(24).

To a solution of the allenyl product 13 (0.09 g, 0.29 mmol) in dry THF (1 mL) was
added sodium hydride (60% in mineral oil, 16.00 mg, 0.59 mmol, 2.0 equiv.) at 0 °C.
The reaction was stirred at room temperature for 60 min. Then, the reaction mixture
was quenched with saturated aqueous NH4Cl solution (5 mL), washed with water (10
mL)

and

dried

(MgSO4).

Purification

by

flash

column

chromatography

(EtOAc/hexane 3:7) afforded the corresponding oxazolidinone product 24. Light
yellow oil (0.035 g, 52%). Rf (EtOAc/hexane 3:7) = 0.40. 
 = −56.7 (c 1.7
CHCl3). 1H NMR (300 MHz, CDCl3) δ 1.14 (d, 3H, J = 6.6 Hz, CH3), 3.69-3.78 (m,
1h, CH), 4.03 (d, 1H, J = 15.3 Hz, CHPh), 4.82 (d, 1H, J = 15.0 Hz, CHPh), 4.86-4.98
(m, 3H, CH2=C= and CH), 5.17-5.24 (m, 1H, CH=C=), 7.25-7.37 (m, 5H, 5CHAr).
13

C{1H} NMR (75 MHz, CDCl3) δ 13.7, 45.7, 53.3, 76.1, 77.6, 86.1, 127.9, 128.0,

128.8, 135.9, 157.5, 209.7. IR (νmax/cm-1) 2924 (w), 2358 (w), 1358 (w), 1743 (s),
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1675 (m), 1414 (s), 1243 (m), 1159 (m), 761 (m), 700 (s). HRMS (ESI-TOF) m/z
calcd for C14H15NO2Na [M + Na]+ 252.1000, found 252.1003.

(S)-N-benzyl-1-((R)-2,5-dihydrofuran-2-yl)ethan-1-amine (25a). Following
the general procedure B using 0.065 g, 0.24 mmol of 6a, the resulting crude of 13 was
treated with AuPPh3NTf2 (17.50 mg, 0.024 mmol, 10 mol%), followed by Bocdeprotection of the crude product by treatment with chlorotrimethylsilane (0.14 mL,
1.20 mmol, 5 equiv.) in methanol (2 mL). The title compound 25a was obtained as a
single diastereomer after purification by flash column chromatography (Et2O/hexane
7:3). The isolated yield was calculated for the three steps starting from the aldehyde
6a. Colorless oil (0.03 g, 60%). Rf (Et2O/hexane 7:3) = 0.15. The ee was determined
by chiral HPLC of the corresponding alcohol using a Phenomenex Lux Cellulose-3
column; hexane/isopropanol (98:2); flow rate = 0.5 mL/min; 210 nm; tmajor = 9.83
1
min, tminor = 10.95 min, 91% ee. 
 = +104.5 (c 0.9 CHCl3). H NMR (500 MHz,

CDCl3) δ 1.06 (d, 3H, J = 6.5 Hz, CH3), 1.69 (s, 1H, NH), 2.85-2.88 (m, 1H, CH),
3.79 (d, 1H, J = 13.5 Hz, CHPh), 3.90 (d, 1H, J = 13.5 Hz, CHPh), 4.62-4.69 (m, 2H,
CH2), 4.87-4.88 (m, 1H, CH), 5.81-5.82 (m, 1H, CH), 5.95-5.97 (m, 1H, CH), 7.217.33 (m, 5H, 5CHAr). 13C{1H} NMR (125 MHz, CDCl3) δ 15.6, 51.4, 55.5, 75.7, 89.4,
126.8, 127.0, 127.7, 128.0, 128.3, 140.7. IR (νmax/cm-1) 3327 (w), 3026 (w), 2964
(w), 2845 (m), 1683 (m), 1630 (m), 1494 (m), 1452 (m), 1355 (m), 1269 (m), 1068
(s), 1028 (s), 950 (s), 847 (m), 731 (s), 696 (s). HRMS (ESI-TOF) m/z calcd for
C13H18NO [M + H]+ 204.1388, found 204.1393.

(S)-N-benzyl-1-((R)-2,5-dihydrofuran-2-yl)butan-1-amine

(25b).

The

allenyl precursor was prepared following B the general procedure using tert-butyl
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benzyl(1-oxopentan-2-yl)carbamate 6b (0.485 g, 1.66 mmol), allenylboronic acid
pinacol ester 1 (0.41 mL, 2.16 mmol, 1.3 equiv.) and Et2Zn (1M in toluene, 180 µL,
0.048 mmol, 10 mol%) in dry toluene (5 mL). Following the general procedure B the
crude allenyl product was treated with AuPPh3NTf2 (0.117 g, 0.16 mmol, 10 mol%)
in dry dichloroethane (5 mL). Boc-deprotection of the resulting dihydrofuran with
chlorotrimethylsilane (0.95 mL, 8.00 mmol, 5 equiv.) in methanol (5 mL) gave the
title compound 25b as a 4.3:1 mixture of syn and anti diastereomers after purification
by flash column chromatography (Et2O/hexane 2:8). The isolated yield was calculated
for the three steps starting from the aldehyde 6b. Colorless oil (0.26 g, 68%), Rf
(Et2O/hexane 2:8) = 0.30.

1

H NMR (300 MHz, CDCl3) (mixture of two

diastereomers, relative integrations given for each diastereomer) δ 0.88 (t, 3H, J =
6.30, 6.9 Hz, CH3, for each isomer), 1.28-1.49 (br m, 2H, CH2, for each isomer), 2.502.60 (m, 1H, CH, minor isomer), 2.69 (q, 1H, J = 8.5, 10.5 Hz, CH, major isomer),
3.80 (s, 2H, CH2Ph, minor isomer), 3.83 (s, 2H, CH2Ph, major isomer), 4.58-4.70 (m,
2H, CH2, for each isomer), 4.84-4.86 (m, 1H, CH, minor isomer), 4.93-4.94 (m, 1H,
CH, major isomer), 5.81-5.83 (m, 1H, CH=, for each isomer), 5.90-5.96 (m, 1H, CH=,
for each isomer), 7.18-7.30 (m, 5H, 5CHAr, for each isomer).

13

C{1H} NMR (75

MHz, CDCl3) (mixture of two diastereomers, minor indicated by asterisk) δ 14.3,
14.4*, 19.3*, 19.5, 33.1*, 33.3, 51.8*, 52.3, 60.2, 60.3*, 75.3*, 75.4, 88.3*, 88.6,
126.7, 127.2, 127.4*, 127.7, 127.8, 128.0*, 128.2, 140.9. IR (νmax/cm-1) 3735 (w),
2956 (m), 2871 (m), 2844 (m), 1457 (m), 1354 (w), 1073 (s), 734 (s), 696 (s). HRMS
(ESI-TOF) m/z calcd for C15H21NONa [M + Na]+ 254.1521, found 254.1531.

(S)-N-benzyl-1-((R)-2,5-dihydrofuran-2-yl)-3-methylbutan-1-amine (25c).
The allenyl precursor was prepared following B the general procedure using tert-butyl
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benzyl(4-methyl-1-oxopentan-2-yl)carbamate 6c (0.198 g, 0.65 mmol), allenylboronic
acid pinacol ester 1 (160 µL, 0.84 mmol, 1.3 equiv.) and Et2Zn (1 M in toluene, 70
µL, 0.065 mmol, 10 mol%) in dry toluene (2 mL). Following the general procedure
B the crude allenyl product was treated with AuPPh3NTf2 (44.90 mg, 0.06 mmol, 10
mol%) in dry dichloroethane (2 mL). Boc-deprotection of the resulting dihydrofuran
with chlorotrimethylsilane (0.38 mL, 3.25 mmol, 5 equiv.) in methanol (3 mL) gave
the title compound 25c as a 3.2:1 mixture of syn and anti diastereomers after
purification by flash column chromatography (Et2O/hexane 2:8). The isolated yield
was calculated for the three steps starting from the aldehyde 6c. Colorless oil (0.097
g, 62%), Rf (Et2O/hexane 2:8) = 0.36. 1H NMR (300 MHz, CDCl3) (mixture of two
diastereomers, relative integrations given for each diastereomer) δ 0.81-0.92 (m, 6H,
2CH3, for each isomer), 1.22-1.33 (m, 1H, CH, for each isomer), 1.74-2.00 (m, 1H,
CH, for each isomer), 2.77-2.81 (m, 1H, CH, major isomer), 2.85-2.89 (m, 1H, CH,
minor isomer), 3.28 (s, 1H, NH, minor isomer), 3.34 (s, 1H, NH, major isomer), 3.823.92 (m, 2H, CH2Ph, for each isomer), 4.65-4.69 (m, 2H, CH2O, for each isomer),
4.97-5.00 (m, 1H, CH, for each isomer), 5.80-5.82 (m, 1H, CH=, for each isomer),
5.97-6.00 (m, 1H, CH=, for each isomer), 7.23-7.35 (m, 5H, 5CHAr, for each isomer).
13

C{1H} NMR (75 MHz, CDCl3) (mixture of two diastereomers, minor indicated by

asterisk) δ 22.3, 23.5, 24.9, 40.4, 52.3, 54.0*, 58.2, 75.5, 88.8, 127.1, 126.8, 127.9*,
128.2, 128.33*, 128.36, 140.9. IR (νmax/cm-1) 3735 (w), 2956 (m), 2926 (m), 2868
(m), 1457 (m), 1131 (m), 1074 (m), 740 (m), 697 (m), 619 (m). HRMS (ESI-TOF)
m/z calcd for C16H24NO [M + H]+ 246.1858, found 246.1854.

(S)-N-benzyl-1-((R)-2,5-dihydrofuran-2-yl)-2-methylpropan-1-amine
(25d). The allenyl precursor was prepared following the general procedure B using
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tert-butyl benzyl(3-methyl-1-oxobutan-2-yl)carbamate 6d (0.53 g, 1.84 mmol),
allenylboronic acid pinacol ester 1 (454 µL, 2.40 mmol, 1.3 equiv.) and Et2Zn (1 M in
toluene, 197 µL, 0.184 mmol, 10 mol%) in dry toluene (5 mL). Following the general
procedure B the crude allenyl product was treated with AuPPh3NTf2 (0.13 g, 0.18
mmol, 10 mol%) in dry dichloroethane (5 mL). Boc-deprotection of the resulting
dihydrofuran with chlorotrimethylsilane (1.12 mL, 9.20 mmol, 5 equiv.) in methanol
(5 mL) gave the title compound 25d as a single diastereomer after purification by
flash column chromatography (Et2O/hexane 2:8). The isolated yield was calculated
for the three steps starting from the aldehyde 6d. Colorless oil (0.263 g, 61%). Rf
1
(Et2O/hexane 2:8) = 0.22. 
 = -43.3 (c 0.65 CHCl3). H NMR (500 MHz, CDCl3)

δ 0.98 (d, 6H, J = 6.5 Hz, 2CH3), 1.84-1.87 (br m, 2H, CH, NH), 2.37 (br d, 1H, J =
3.0 Hz, CH), 3.83 (dd, 2H, J = 13.0, 12.5 Hz, CH2Ph), 4.64 (br d, 2H, J = 13.0 Hz,
CH2), 4.95 (br s, 1H, CH), 5.80 (br s, 1H, CH=), 5.93 (br s, 1H, CH=), 7.22-7.32 (m,
5H, 5CHAr).

13

C{1H} NMR (125 MHz, CDCl3) δ 19.28, 20.2, 30.7, 53.9, 65.7, 75.6,

87.9, 126.9, 127.2, 128.4, 129.2, 141.5. IR (νmax/cm-1) 2955 (m), 2872 (m), 2359 (w),
1457 (m), 1070 (s), 1028 (s), 739 (s), 697 (s). HRMS (ESI-TOF) m/z calcd for
C15H22NO [M + H]+ 232.1701, found 232.1703.

(S)-N-benzyl-1-((R)-2,5-dihydrofuran-2-yl)-2-phenylethan-1-amine (25e).
The allenyl precursor was prepared following the general procedure B using tert-butyl
benzyl(1-oxo-3-phenylpropan-2-yl)carbamate

6e

(0.278

g,

0.82

mmol),

allenylboronic acid pinacol ester 1 (0.20 mL, 1.06 mmol, 1.3 equiv.) and Et2Zn (1 M
in toluene, 85.00 µL, 0.082 mmol, 10 mol%) in dry toluene (2 mL). Following the
general procedure B the crude allenyl product was treated with AuPPh3NTf2 (60.00
mg, 0.08 mmol, 10 mol%) in dry dichloroethane (3 mL). Boc-deprotection of the
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resulting dihydrofuran with chlorotrimethylsilane (0.52 mL, 4.10 mmol, 5 equiv.) in
methanol (3 mL) gave the title compound 25e as a 8.3:1 mixture of syn and anti
diastereomers after purification by flash column chromatography (EtOAc/hexane
3:7). The isolated yield was calculated for the three steps starting from the aldehyde
6e. Light yellow oil (0.133 g, 58%). Rf (EtOAc/hexane 3:7) = 0.34. 1H NMR (500
MHz, CDCl3) (mixture of two diastereomers, relative integrations given for each
diastereomer) δ 2.70-2.74 (m, 1H, CHPh, for each isomer), 2.80-2.83 (m, 1H, CHPh,
for each isomer), 2.90 (s, 1H, CH, minor isomer), 2.98 (br s, 1H, CH, major isomer),
3.77 (q, 2H, J = 13.5 Hz, CH2Ph, for each isomer), 4.63-4.73 (m, 2H, 2CH−O, for
each isomer), 4.89 (br s, 1H, CH, for each isomer), 5.78 (br s, 1H, CH=, minor
isomer), 5.89 (br s, 1H, CH=, major isomer), 5.98 (br s, 1H, CH=, for each isomer),
7.12-7.27 (m, 10H, 10CHAr, for each isomer).

13

C{1H} NMR (125 MHz, CDCl3)

(mixture of two diastereomers, minor indicated by asterisk) δ 37.1, 37.4*, 52.10,
52.16*, 61.80, 61.85*, 75.5*, 75.6, 87.8*, 88.0, 126.1*, 126.2, 126.7, 127.2, 127.73*,
127.79*, 128.0, 128.3, 128.4, 129.3, 139.2, 139.5*, 140.5. IR (νmax/cm-1) 3333 (w),
3026 (w), 2844 (m), 1494 (m), 1452 (m), 1070 (s), 739 (s), 696 (s). HRMS (ESITOF) m/z calcd for C19H22NO [M + H]+ 280.1695, found 280.1697.

tert-Butyl 3-((S)-2-(benzylamino)-2-((R)-2,5-dihydrofuran-2-yl)ethyl)-1Hindole-1-carboxylate (25f). The allenyl precursor was prepared following the general
procedure B using tert-butyl 3-(2-(benzyl(tert-butoxycarbonyl)amino)-3-oxopropyl)1H-indole-1-carboxylate 6f (0.389 g, 0.81 mmol), allenylboronic acid pinacol ester 1
(0.20 mL, 1.05 mmol, 1.3 equiv.) and Et2Zn (1 M in toluene, 87.30 µL, 0.081 mmol,
10 mol%) in dry toluene (3 mL). Following the general procedure B the crude allenyl
product was treated with AuPPh3NTf2 (59.15 mg, 0.08 mmol, 10 mol%) in dry
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dichloroethane (4 mL). Boc-deprotection of the resulting dihydrofuran with
chlorotrimethylsilane (0.52 mL, 4.05 mmol, 5 equiv.) in methanol (5 mL) gave the
title compound 25f as a single diastereomer after purification by flash column
chromatography (EtOAc/hexane 3:7). The isolated yield was calculated for the three
steps starting from the aldehyde 6g. Light yellow oil (0.163 g, 48%). Rf
1
(EtOAc/hexane 3:7) = 0.33. 
 = +39.3 (c 1.3 CHCl3). H NMR (300 MHz,

CDCl3) δ 1.66 (br s, 9H, C(CH3)3), 2.76-2.92 (m, 2H, CH2), 3.07-3.13 (m, 1H, CH),
3.81 (dd, 2H, J = 13.2, 13.5 Hz, CH2Ph), 4.63-4.78 (m, 2H, CH2), 4.95 (br s, 1H, CH),
5.93 (br dd, 1H, J = 1.2, 0.9 Hz, CH), 6.01 (d, 1H, J = 6.3 Hz, CH), 7.16-7.21 (br m,
5H, 5CHAr), 7.25-7.32 (m, 2H, 2CHAr), 7.44 (t, 2H, J = 12.6, 7.8 Hz, 2CHAr), 8.12 (br
d, 1H, J = 13.2 Hz, CHAr). 13C{1H} NMR (75 MHz, CDCl3) δ 26.3, 28.2, 52.1, 60.0,
75.6, 83.3, 88.1, 115.2, 117.7, 119.1, 122.3, 123.6, 124.3, 126.7, 127.2, 127.9, 128.0,
128.2, 130.7, 135.5, 140.3, 149.6. IR (νmax/cm-1) 3670 (w), 2978 (w), 2842 (w), 1729
(s), 1451 (s), 1367 (s), 1255 (s), 1155 (s), 1072 (s), 1015 (m), 935 (m), 856 (m), 743
(s), 697 (s). HRMS (ESI-TOF) m/z calcd for C26H31N2O3 [M + H]+ 419.2335, found
419.2346.

tert-Butyl

(S)-2-((R)-2,5-dihydrofuran-2-yl)pyrrolidine-1-carboxylate

(25g). The allenyl precursor was prepared following the general procedure B using
tert-butyl 2-formylpyrrolidine-1-carboxylate 6g (0.29 g, 1.45 mmol), allenylboronic
acid pinacol ester 1 (0.36 mL, 1.89 mmol, 1.3 equiv.) and Et2Zn (1 M in toluene,
156.3 µL, 0.145 mmol, 10 mol%) in dry toluene (3 mL). Following the general
procedure B the crude allenyl product was treated with AuPPh3NTf2 (107.4 mg, 0.145
mmol, 10 mol%) in dry dichloroethane (3 mL). The title compound 25g was obtained
as a 1.6:1 mixture of syn and anti diastereomers after purification by flash column
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chromatography (Et2O/hexane 3:7). The isolated yield was calculated for the two
steps starting from the aldehyde 6g. Colorless oil (0.21 g, 59%), Rf (Et2O/hexane 3:7)
= 0.18. 1H NMR (500 MHz, DMSO, 80 °C) (mixture of two diastereomers, relative
integrations given for each diastereomer) δ 1.41 (s, 9H, C(CH3)3, for each isomer),
1.70 (br s, 2H, 2CH2, major isomer), 1.80-1.85 (m, 4H, 2CH2, minor isomer) 3.143.22 (m, 2H, CH2, major isomer), 3.31 (br s, 2H, CH2, minor isomer), 3.75 (s, 1H,
CH, major isomer), 3.90 (s, 1H, CH, minor isomer), 4.47-4.54 (m, 2H, CH2, for each
isomer), 4.97 (br s, 1H CH, for each isomer), 5.79-5.81 (m, 1H, CH=, for each
isomer), 6.02 (br s, 1H, CH=, for each isomer). 13C{1H} NMR (125 MHz, DMSO, 80
°C) (mixture of two diastereomers, minor indicated by asterisk) δ 23.9, 25.7, 28.61,
28.66*, 46.9*, 47.1, 59.7*, 60.6, 75.6, 78.7, 78.8*, 87.4, 127.2*, 128.0, 128.3, 128.4*,
154.0, 154.3*. IR (νmax/cm-1) 2972 (m), 2878 (m), 2845 (m), 2355 (w), 1687 (s), 1456
(m), 1388 (s), 1363 (s), 1255 (m), 1165 (s), 1109 (s), 1072 (s), 769 (m), 678 (m).
HRMS (ESI-TOF) m/z calcd for C13H21NO3Na [M + Na]+ 262.1419, found 262.1427.
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